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ABSTRACT OF THE DISSERTATION
OUTCOMES OF TRANSITION TO ADULT HIV CARE
IN PERINATALLY HIV-INFECTED YOUNG ADULTS
by
Susan Biersteker
Florida International University, 2016
Miami, Florida
Professor Consuelo Beck-Sagué, Major Professor
Transitioned perinatally HIV-infected patients may be at increased risk for poor
outcomes, yet the impact of transition and of transition programs on health are not well
understood. This research examined: (1) post-transition mortality, (2) engagement in
adult HIV care, (3) transition experiences, and clinical and sociodemographic influences,
including transition program exposure.
Data were collected from patients who had transitioned from a Florida pediatric
clinic to adult HIV care between January 2003 and September 2012. Post-transition
mortality and care engagement were assessed in a retrospective analysis of medical
record data. Fisher exact and Kruskal-Wallis tests were used for significance testing. Risk
ratios (RRs) were calculated to assess strength of associations. Stratified analysis
controlled for confounding. Transition experiences were examined in a mixed-methods
study, with qualitative data from a computer-assisted survey subjected to thematic
analysis.
Of 51 transitioned patients, nine (18%) had died by May 2014, five (56%) in the
first post-transition year. Of 42 survivors, 33 were eligible; 27 (82%) provided consent.
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Post-transition mortality was high, particularly in those severely immunosuppressed
(CD4 count <100/mm3; RR =6.0, 95% CI =1.88-19.19 [P=.005]) at transition. When
controlled for CD4 count, employment was associated with decreased (adjusted RR=
0.19; 95% CI=0.04-0.88 [P=.02]), and high school non-completion with increased
(adjusted RR= 3.0; 95% CI=1.37-6.40 [P=.07]) mortality risk. The number of kept HIV
appointments decreased from last pre-transition (Median = 5, IQR 4-6) to first posttransition (Median = 2, IQR 1-10; P=.002) year; the proportion of poorly engaged
increased from 3% to 35% (P=.006), with no significant changes between first and
second post-transition years. Non-Hispanic black and low-income participants were less
likely to be regularly engaged in adult HIV care one year post-transition. Transition
program exposure did not significantly affect mortality or care engagement. Most of 27
received transition services, but 59% had trouble doing well in adult care. Needs for
patient-centered care, with caring, personal patient-provider relationships and accessible
HIV care, characterized post-transition experiences.
This research suggested that transitioned perinatally HIV-infected young adults
are at risk for poor health outcomes. Systematic programs using a socio-ecological
framework to include multi-level interventions and post-transition support may improve
outcomes.
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CHAPTER I
INTRODUCTION
Epidemiological Changes in Perinatal HIV Cases
Medical advances since the mid-1990s greatly improved the life expectancy of
children infected with HIV early in life.1,2 With widespread access to combination
antiretroviral therapy (cART) -especially in industrialized or developed countries- many
perinatally HIV-infected (PHIV) children who were expected to die in early childhood,
now survive into adolescence, young adulthood and beyond.3 Simultaneously, effective
interventions to prevent mother-to-child transmission, including cART therapies,
significantly reduced the number of children born with HIV. Without interventions,
perinatal transmission rates are estimated at 18% to 32%.4 Currently, transmission rates
in the United States (US) are 1-2%; national policies aim for a reduction to <1%, which is
regarded as feasible if sufficient and adequate resources are employed to deliver all
recommended interventions to prevent mother-to-child transmission.5
In the US, the pediatric HIV population1 consists of a relatively stable group of
approximately 10,000 infected children, adolescents, and young adults, with the addition
of less than 100 new cases annually.6,7 As a consequence of epidemiologic trends, most
US PHIV children are now adolescents and young adults.6-8 Significant racial/ethnic
health disparities exist in PHIV, as demonstrated in the state of Florida. Black infants
accounted for 75% of the pediatric HIV cases reported through 2012, while only 21% of
the Florida population is Black.9 Like most HIV-infected heterosexual women and men,

1

Pediatric cases include children infected with HIV prior to age 13; 95% of pediatric cases are perinatallyacquired HIV.
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most PHIV children are poor and live in urban, impoverished neighborhoods, where HIV
prevalence is 20 times greater than among US heterosexuals overall.10,11
New Challenges in HIV Treatment and Care
Long term survival of PHIV children poses new care and treatment challenges.
The growing cohort of adolescents and young adults with PHIV requires lifelong
treatment to control for viral replication, prevent immune deterioration and transmission
of HIV.12 They were infected before development of their immune systems, and most are
significantly treatment experienced, often with suboptimal mono- and dual antiretroviral
regimens before more effective triple regimens became available.7,13,14 Many PHIV
adolescents and young adults will be in advanced stages of HIV disease and have
complex medical histories, complicating treatment and limiting therapy options.15 As
more PHIV children grew older, high risks of treatment failure and antiretroviral
resistance, and long term complications of lifetime HIV disease, including metabolic
disorders and neurocognitive impairment, became evident.12,13 With effective cART,
AIDS dementia and encephalopathy have almost disappeared in the United States, but
concerns regarding more subtle central nervous system and learning disabilities have
emerged.13,16 Higher rates of psychiatric symptoms, particularly attention deficit-disorder
and depression, were reported in HIV infected youth compared to uninfected youth from
similar socioeconomic backgrounds.17 Explanatory, multifactorial, causes include
biological (e.g. HIV-associated neurocognitive disorder) factors, treatment complications,
including disfiguring adverse effects (e.g. lipodystrophy), and psychosocial factors,
including living with a chronic illness, loss of parents, and HIV/AIDS stigma.
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With the transformation of HIV from a fatal to a chronic disease, the goal of HIV
care has shifted toward achieving long-term optimal health outcomes through consistent
ART adherence and responses. Continuous care is essential for all people with HIVinfection, as even short lapses in HIV care may have significant consequences for viral
suppression, drug resistance, and HIV transmissibility.18 As PHIV children mature, they
may be less likely to adhere to HIV appointment schedules and ART regimens, compared
to younger children and HIV-infected adults. While retaining HIV-infected patients in
medical care at regular intervals results in better health outcomes,19 studies reported
prolonged poor engagement in adult HIV care extending from adolescence through
young adulthood.20 Viral suppression can be achieved with adherence levels of 54% 100% to newer, more potent non-nucleoside reverse transcriptase and boosted protease
inhibitor containing cART regimens.21 Nevertheless, perfect adherence remains an
important goal; self-reported adherence among HIV-infected youth was reported between
40%-84%, and tends to be lower than in adults.12
Long-term survival of youth also comes with unanticipated needs in reproductive
health, higher education, and employment.13 Growing autonomy and independence,
formation of intimate relationships, and management of education and employment may
be difficult for all adolescents. These issues may be particularly challenging for PHIV
adolescents as they have to be managed in the context of HIV disease and care,
HIV/AIDS stigma, and economic and social stress.22
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Transition from Pediatric to Adult Care
Long-term survival is also accompanied by the need for a “seamless” health care
transition from pediatric or adolescent services to adult HIV care settings to ensure
continuous HIV care. Most US pediatric or adolescent clinics follow their patients up to
age 24-25 years, after which patient care has to be transferred to adult HIV providers.
With the ‘coming of age’ of the largest cohort of PHIV children (infected between early
1980’s and late 1990’s), more patients than ever before will transfer from pediatric or
adolescent services to adult care in the next decade.23 Transition from pediatric and
adolescent clinical services to adult care is widely regarded to be challenging, largely
because of fundamental differences between pediatric and adult HIV care models.22,24
Most pediatric and adolescent clinics have long-established relationships with their
patients, and offer comprehensive ‘one-stop’ services in a familiar and nurturing
environment. In contrast, adult clinical services tend to be less accommodating and more
impersonal, and require patients to self-manage their HIV disease and independently
navigate fragmented adult health care systems. PHIV young adults may not have the
functional autonomy presumed in adult HIV care.25 As PHIV children in the US
disproportionally belong to poor racial or ethnic minority communities, psychosocial
issues, including living in impoverished neighborhoods, poverty, and HIV/AIDS stigma,
may further complicate successful transition.11 These issues may be exacerbated by the
complexity of the US healthcare system, and the under-resourced and stressed system of
HIV care for patients who depend on public health insurance.26,27
Recognizing the risks associated with poor health care transition, with
transitioned PHIV young adults becoming sub optimally engaged in adult HIV care or
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being lost to care, successful transition has become a key aspect in maintaining the health
of PHIV adolescents and young adults.8,28 Consequently, transition programs and services
to prepare patients for a ‘smooth’ transition have become a key component of pediatric or
adolescent care.
Literature Review: Transition from Pediatric/Adolescent to Adult HIV Care
Transition of medical care is not simply an administrative procedure. It refers to
the purposeful, planned preparation of adolescents and young adults with chronic
physical and medical conditions, their families, and their caregivers to successfully
transfer from comprehensive, child-centered, care to adult-oriented care.29 Successful
transition requires autonomy in all realms of life, including taking personal control over
health issues, coming to terms with sexual orientation, and planning of future educational
and vocational goals.23
Health care transition first evolved as a concept of care several decades ago, when
prognosis improved for children diagnosed with other pediatric conditions than HIV,
including cancer, cystic fibrosis and type 1 diabetes.30 In 1984, US Surgeon C. Everett
Koop hosted the first national conference “Youth with Disability: The Transition Years,”
to describe emerging needs and transition challenges.31 Five years later, the Surgeon
General’s conference entitled “Growing Up and Getting Medical Care: Youth with
Special Health Care Needs,” developed the first national agenda to develop specific
strategies and action steps to establish a seamless health care transition from childcentered to adult-centered medical services.31 In the following years, the Society of
Adolescent Medicine,29 US Department of Health and Human Services, 28 Academy of
Pediatrics,8 and others professional organizations published transition recommendations
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and guidelines. Despite these efforts, modest progress has been made. There still is an
urgent need for coordinated, integrated and evidence-based transition services and
programs for adolescents and young adults with chronic diseases.22,32
PHIV young adults, due to their more recent improvement in survival, have been
relatively understudied. To date, the transition literature has focused on understanding
issues young people with HIV face as they “age out” of pediatric or adolescent care.
‘State-of-the-Art’ review articles concluded that most studies utilized qualitative research
methods to explore anticipated transition barriers from the perspectives of youth who still
had to transition, their caregivers and providers.24,33,34 Across various studies, transition
is considered to be challenging because of the loss of longstanding, familiar relationships
with pediatric providers, anxieties about increased responsibility for disease management
and presumed medical independence in adult HIV care.35-40 Logistical challenges,
including medical insurance and access to medical and social services, may further
complicate transition.
Similar barriers were first discussed at the first national conferences on needs of
children with chronic diseases in the 1980s, and were commonly described in following
studies of young adults with chronic diseases.30,31,41,42 Transitioning adolescents and
young adults with chronic diseases share the burden of lifetime disease management and,
therefore, may face comparable transition barriers. However, unique challenges including
HIV/AIDS stigma and discrimination, disclosure-related issues, and the risk of secondary
transmission, may further complicate transition of young adults with HIV2.44 HIV/AIDS
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Young adults with HIV includes youth with perinatally and behaviorally acquired HIV-infection.
Although the course of infection differs, transition challenges and outcomes may be similar.8,43
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is also different from some other chronic diseases as it disproportionally impacts socially
and economically marginalized populations.11 Racial and ethnic disparities in transition
success are relatively unexamined. Some evidence from studies of youth with chronic
diseases indicated that youth from racial and ethnic minorities received less adequate
transition preparation, while low-income youth were found to be at higher risk of
experiencing gaps in access to care as they aged into adulthood compared to their
counterparts with higher incomes.27 Qualitative studies of young adults with HIV
suggested that adverse social conditions may be barriers to successful transition,
including lack of transportation and stable housing, unemployment, food insecurity, and
problems obtaining and accessing health insurance.11,25,37
The paucity of transition outcome data and the lack of evidence-based transition
programs are widely recognized as the most important gaps in the transition literature.33
Concerns about poor transition outcomes of PHIV young adults were primarily based on
anecdotal information of pediatric providers, and on findings of studies of youth with
chronic diseases other than HIV disease. These studies showed poorer outpatient clinic
attendance, poorer adherence to medications, and increased morbidity and mortality after
transition to adult clinical care.38 However, little is known about clinical outcomes of
transitioned PHIV young adults, as few pediatric or adolescent clinics track their patients
after they leave their care.13,37 Post-transition mortality has been assessed in England and
Ireland. This retrospective study reported a relatively - compared to adults with HIVhigh mortality rate (4%) in a cohort of transitioned PHIV adolescents and young adults.45
A study conducted in the US reported a non-significant downward trend in immune status
(self-reported CD4+ T-lymphocyte [CD4] count) in a cohort of US transitioned PHIV
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young adults.38 A recent retrospective study of transitioned patients with behavioral and
perinatally-acquired HIV concluded that the health care transition process needs to be
optimized as only 50% of patients were retained in adult HIV care one year posttransition, and had completed at least two clinical visits 43 Additionally, cross-sectional
studies suggested that health may decline after transition to adult HIV care. Poorer
clinical outcomes were documented in patients seen in adult HIV care compared to their
peers in pediatric care,46,47 and HIV-infected adult patients. 48 Recent studies reported
prolonged poor engagement in adult HIV care extending from adolescence through
young adulthood (25-34 years old).20 Loss-to-follow-up was found to be associated with
receiving care at adult clinical settings.49
Acknowledging the risk of poor transition outcomes, transition services and
programs became a key component of pediatric or adolescent care.8,28 Many US
pediatric or adolescent HIV clinics have developed and implemented transition programs
and services for HIV-infected youth.37 In the tradition of chronic diseases, selfmanagement became the central focus of transition programs for adolescents and young
adults with HIV. For example, in the policy statement “Transitioning HIV-infected youth
into adult health care” of the American Academy of Pediatrics (2013), it was stated that
“Seamless and successful transition from pediatric to adult-oriented care is
dependent on these youth acquiring skills to allow them to be responsible for their
management of their own health care. A well-planned transition enables youth to
optimize their ability to assume adult roles and responsibilities.” 8(p193)
Although the importance of transition preparations and programs for transition
success of PHIV young adults is widely supported, there is no high quality evidence
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available to inform policies and programs. Strategies and clinical recommendations for
successful transitioning, including development of formal transition plans, assurance of
transition readiness, optimizing communication between adolescent and adult clinics,
educational, employment and life-skills training, were proposed, but it’s not clear how
effective these interventions are in improving health outcomes.8,28 Likewise, workbooks
by the National Resource Centers of the AIDS Education and Training Centers to assist
providers to prepare their patients for transition were developed, but - to our knowledge not evaluated.24 In addition, of the few published protocols or models for HIV specific
health care transition, only one (pilot) evaluation of the “Movin’ Out” for behaviorally
HIV-infected young adults was published.50
Evidence-based transition models may be unavailable because transition of HIVinfected young adults is a relatively new phenomenon.37 However, despite the fact that
the concept of health care transition was developed decades ago, little high quality
evaluation of transition programs for youth with chronic diseases has been
published.30,51,52 Methodological issues, including lack of well-defined outcome
indicators, poorly described interventions, problems in including comparisons groups and
measuring separate effects of comprehensive interventions, and a lack of dedicated
funding for program development, implementation and evaluation are considered to be
major barriers to the development of evidence-based transition programs.51
Statement of the Problem
As the prognosis for HIV disease has improved, an increasing number of PHIV
children are living well into adulthood.53 With the “coming of age” of the largest cohort
of PHIV children, more young adults than ever before will transition from pediatric or
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adolescent services to adult clinical care in the next decade.23 Management of HIV
disease in medically and socially vulnerable PHIV adolescents and young adults is
challenging, and requires lifelong treatment and excellent medication adherence to
achieve viral suppression, and prevent deterioration of immunologic status and secondary
transmission.12
Largely because of system differences between pediatric and adult HIV care
settings, transition may be associated with poor health outcomes with potentially negative
consequences for both personal and public health.8 Because of the risk of poor transition
outcomes, with PHIV young adults becoming sub optimally engaged in adult HIV care or
being lost to follow-up, transition programs to prepare adolescents and young adults for a
smooth, successful, transition became a key component of pediatric or adolescent care.
However, transitioning of PHIV young adults is a new phenomenon who remain
understudied. Studies examining outcomes of transition and effects of HIV-specific
transition programs are needed to establish theory- and evidence-based programs to support
transitioning young adults. This study addresses gaps in the transition literature by
assessing health outcomes and the effect of a transition program for PHIV young adults
who transitioned from a pediatric outpatient HIV clinic in South Florida. Clinic staff
wanted to know: (1) How their transitioned patients were doing post-transition; (2) If the
transition program had helped their patients to transition, and (3) What improvements to
the transition program were needed.
Study Context: Pediatric Clinic in South Florida
This study was initiated on request of the Infectious Diseases & Immunology
pediatric clinic, University of Miami, located in Miami, Florida. Florida is among the
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states with the highest HIV/AIDS prevalence and HIV incidence in the nation, with the
highest HIV/AIDS burden in South Florida.54 Through 2013, Florida ranked second (only
to New York State) in the number of pediatric AIDS cases.55
The pediatric clinic is a partner of the Miami Family Care Program, which was
one of the 13 original Pediatric AIDS Health Care Demonstration Projects in 1988, and
has been funded through the Health Resources and Services Administration’s (HRSA)
Ryan White Part D program since incorporation in the Ryan White Care Act in 1994. The
clinic provides out-patient, multi-disciplinary, and family-based healthcare services to
low-income and underserved children, adolescents, and young adults up to 25 years in
age who acquired HIV early in life, nearly all through vertical transmission. Currently,
most of the approximately 160 patients are adolescents or young adults. Funding for
supportive or ancillary services is largely unavailable in the adjacent adult public
hospital, with about 2,700 adult HIV-infected patients, to where most pediatric patients
have transitioned. Consequently, transitioned young adults do not receive the support and
assistance to which they were accustomed in comprehensive pediatric HIV care,
including but not limited to: follow-up in case of missed appointments, counseling and
home delivery services to support medication adherence, and assistance with housing,
transportation and completion of insurance paper work.
Study Context: Comprehensive Transition Program
Since 2008, the pediatric clinic has received funding to implement a
comprehensive transition program to address concerns about high attrition rates and nonadherence to medical appointments and medication regimens after patients transitioned to
adult HIV care. The transition program aimed to facilitate a smooth transition (Figure 1).
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It was assumed that, in order to maintain health post-transition, patients should be able to
independently navigate adult HIV care and attend regularly scheduled HIV appointments,
adhere to medication regimens, and access case management and supportive services.

Figure 1. Conceptual model of the transition program

The causal chain from determinants to program methods and interventions was
not included in a program plan, in itself a major weakness. Discussions with program
planners a posteriori, and subsequent literature review to describe theoretical
underpinnings, provided the following information on how the program was expected to
cause changes and impact transition outcomes. Health care transition is considered to be a
vocational needs of patients as they move from pediatric to adult care settings.29
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Ad 1. Social Determinants. In theories of social production of disease (or social
determinants), distribution and access to key health-promoting factors (including:
education, income, a safe environment, influence and power) are regarded as more
critical to attainment of health than individual knowledge, attitudes and behaviors.56
According to these theories, patients who completed high school, were employed and
stably housed would have better prospects for transition. As described in Figure 1,
transition program interventions included neurocognitive testing to advise educational
strategies, vocational support, help to access housing and financial aid, in
acknowledgement of the impact of social and economic conditions on the risk on illness,
and on the actions people take to prevent or treat their illness. Examples in Box 1
illustrate postulated links between social determinants and health. These examples not
only clarify possible associations between social determinants and patient’s health and
transition success, but also identify potential program limitations. As interventions are
restricted to individual-level interventions, the social context (including the quality of
education, social services and other neighborhood characteristics, as well as education,
labor and social policies), which may impact patients’ health is largely beyond the
transition program focus and not modifiable through the program’s interventions.
Ad 2: Lack of Continuity between Pediatric and Adult HIV Care. Pediatric and
adult HIV care have been described as “two different worlds.”44 To support patients to
overcome logistic transition barriers, pediatric staff discussed an individual transition
plan with patients, provided referrals to adult HIV physicians and social service
organizations, and transferred patient medical records to the referred physician. If needed,
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pediatric staff would accompany patients to their first appointment. A pediatric social
worker was available to provide support to access services in the first post-transition year.

Ad 3. Lack of Self-management Skills. The change from HIV as an acute condition
rapidly progressing to mortality to a chronic condition has brought emphasis to the
importance of self-management, with patients assuming an active and informed role in
managing physical, psychological, and social aspects of health.64

Because pediatric

providers may treat their patients protectively and expect a lower level of autonomy of their
patients compared to adult providers, interventions to improve self-management of HIV
disease are assumed to be essential to prepare pediatric patients for the requirements of
adult HIV care.8,35 This vision corresponds with the developmental transition model that
recognizes the changing needs of patients for autonomy and the lessened role of family
members or guardian when patients mature.32 Mechanisms to which positive effects of selfmanagement could be attributed is most likely self-efficacy, rather than acquisition of
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knowledge or specific skills.65 Self-efficacy, or the context specific self-confidence that
one can perform required behavior, is the central concept of the self-management theory
and stems from the social-cognitive theory developed by Albert Bandura.66 Common
elements of self-management programs include tasks in the domain of physical health
(including treatment adherence and accessing appropriate treatment and services),
psychological functioning (including: empowerment and reducing negative emotions), and
social relationships (including: collaborative relationships with providers, social support,
and disclosure).64
Self-management programs are systematically planned and goal-oriented.
Although the pediatric clinic’s transition program did not include a systematic plan,
interventions including life skills and support groups, and the transition clinic are based
on the self-management model. Thematic “life-skills” groups were held periodically to
prepare patients for independence. Topics ranged from household skills to medication
adherence, seeking employment, and completion of insurance paperwork. Regular
support groups were offered to help patients deal with social and emotional aspects of
HIV disease. The transition clinic was developed to ‘bridge the gap’ between pediatric
and adult medical HIV care.67 In the year before they transitioned, patients were seen for
routine appointments by an adult provider at the pediatric clinic (pre-transition clinic) to
establish rapport and alleviate anxieties. Subsequently, patients were seen by the same
adult provider at the transition clinic (post-transition clinic) located at the adult clinic site,
for up to one year. A pediatric social worker provided support services during the first
post-transition year. In the second year post-transition, the patient was assumed to be
well-established in adult care and able to navigate services independently. The transition
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clinic and follow-up services temporarily facilitated required behavior and were sources
of self-efficacy to teach patients to solve their problems, including performance
mastering (overcoming obstacles through experience); modelling of expected adult
provider-patient interaction, and social persuasion (including: appraisals from the
pediatric social worker during follow-up).65
Interventions to enable patients to establish a relationship with their future adult
provider pre-transition are based on communication theories. A trusting and respectful
physician-patient relationship is considered to be critical to health management, although
systemic and social barriers may interfere.68 Physician-patient communication
characterized by effective exchange of information and positive affect may lead to greater
patient trust (proximate outcome) and to greater adherence to treatment recommendations
(intermediate outcome), which may lead to positive health outcomes.69 Patients were
invited to meet the adult provider pre-transition to build a trusting relationship and
alleviate their anxieties to break ties with familiar and trusted pediatric providers, but
specific interventions to achieve affective and effective physician-patient communication
were not developed.
Study Aims and Hypotheses
This study was conducted to answer four major questions:
1. What were the health outcomes and experiences of transitioned PHIV young
adults?
2. Were clinical, socioeconomic, and psychosocial vulnerabilities pre-transition
associated with adverse health outcomes post-transition?
3. Did the transition program affect transition outcomes?
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4. How can the transition program be improved?
To answer these questions, three study aims were formulated and accompanying
hypotheses were tested. In this dissertation, each study aim corresponds to a chapter.
Aim 1 To assess post-transition mortality and associated clinical and sociodemographic
factors, including exposure to the transition program.
1.1

H0

Survival does not differ by pre-transition clinical and sociodemographic
patient characteristics.

Halt

Poor health status (low CD4 count and/or high quantitative HIV RNA
plasma levels), socioeconomic vulnerability (including: poverty, low
educational attainment, unemployment, and reliance on public medical
insurance), or psychosocial vulnerability (including: maternal vital status,
and patient relationship status) at time of transition are associated with
post-transition death.

1.2

H0

There are no differences in survival by transition program exposure.

Halt

Transition program exposure decreases mortality risk.

Aim 2 To assess post-transition engagement in adult HIV care and associated clinical
and socio-demographic factors, including exposure to the transition program.
2.1

2.2

H0

No change in engagement in HIV care post-transition.

Halt

Engagement in HIV care decreases post-transition.

H0

Engagement in adult HIV care is not associated with clinical,
sociodemographic, or psychosocial patient characteristics.

Halt

Adverse factors at time of transition, including poor health status (low
CD4 count and/or high quantitative HIV RNA plasma levels), poor
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medical appointment keeping, socioeconomic vulnerability (including:
poverty, low educational attainment, unemployment, and reliance on
public medical insurance), or psychosocial vulnerability (including:
maternal vital status and patients’ relationship status) are associated with
poor engagement in adult HIV care post-transition.
2.3

H0

Exposure to transition program activities is not associated with
engagement in HIV care post-transition.

Halt

Patients who were exposed to the transition program are more likely to
be engaged in adult HIV care compared to unexposed patients.

Aim 3 To describe participants’ satisfaction with the transition program, and assess their
pre-and post-transition experiences in order to develop program recommendations
and contribute to the development of effective, theory- and evidence-based
transition programs.
3.1

Did participants successfully transition? Are they currently regularly engaged in
adult HIV care and able to access needed services? How is their health?

3.2

How did participants experience transitioning to adult HIV care? What has helped
them to transition?

3.3

What were their post-transition experiences? What were their experiences in adult
HIV care? Did they have difficulties with accessing medical and social services,
obtaining medical insurance or experience adherence or health-related problems?

3.4

Based on their experiences, what are their recommendations for improvement of
the transition program?
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CHAPTER II
STUDY DESIGN AND METHODOLOGY
Applied Research
This research was conducted on request of the staff of a pediatric clinic to provide
follow up information on their transitioned patients to inform future program activities
(Attachment 1). Pediatric clinic staff was involved in all study phases. Participation is not
only a fundamental characteristic of health promotion, but also allows the inclusion of
views of informed stakeholders; increases understanding and acceptance of the findings,
and promotes commitment to act on study findings.1
Study Design
A single-center, retrospective cohort study was conducted to assess the health
outcomes mortality (Aim 1) and engagement in HIV care (Aim 2), and associated
sociodemographic and clinical factors, including exposure to transition program
activities. Information was obtained from participants’ medical and social records. To
assist in the interpretation of these quantitative findings and formulation of transition
program recommendations, transition experiences and experiences in adult HIV care
were explored in a mixed-methods explanatory concurrent research design.2 Quantitative
and qualitative data were obtained from a computer-assisted survey and short debriefing
interview (Aim 3).
Study Population and Procedures
Study approval was obtained from the Institutional Review Boards of Florida
International University (IRB-14-0298, most recently on October 19, 2015), and
University of Miami (IRB- 20120433, closure on March 30, 2015) [Attachments 2-3].
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Patients were eligible for study participation if they had transitioned from the Infectious
Diseases & Immunology pediatric clinic, University of Miami, to adult medical HIV care
settings between January 2003 and September 2012. Living patients were excluded from
study participation if they were unable to provide valid informed consent in person
because of severe cognitive disability (as determined by staff psychologists during
routine testing while in pediatric HIV care), incarceration, or relocation. Patients received
care at the pediatric clinic up to age 25; all transitioned patients eligible for study
participation were adults.
Patients who had died post-transition were included. Different recruitment
methods were used to enroll living eligible patients, because transition experiences and
outcomes of patients who successfully transitioned may differ from those who did not.3
Many patients had stayed in contact with the pediatric clinic or with their peers after they
transitioned. They were contacted in person or by phone by the pediatric program
coordinator to introduce the study. The study lead author followed up to provide
additional study information to patients who were interested to participate and set up an
appointment. If up-to-date contact information was unavailable, we asked study
participants to inform their peers about the study. In addition, pediatric clinic staff was
asked to tell former patients about the study, if they contacted the clinic or stopped by.
Per protocol, eligible participants were marked as “refused” if they did not respond to
three attempts to contact them, or if they did respond and declined participation. “Loss to
follow-up” was assigned when current contact information could not be obtained.
Patients willing to participate provided written informed consent (Attachment 4),
and signed HIPAA (Authorization to Use and Disclose Health Information) and
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Authorization of Health Information for 3rd Party Disclosures forms at the pediatric clinic
site. To further protect the privacy of research participants, a confidentiality certificate
from the Department of Health & Human Services was requested and received
(Attachment 5). To enable the patient to make a voluntary and informed decision, consent
was obtained by a researcher who had not been involved in previous care. The consent
form was written in as simple terms as possible, and all patients were able to read and
understand English (per information of the pediatric clinic Ryan White Part D
coordinator). Even so, the researcher read and discussed the consent form with
participants to ensure comprehension.
Study recruitment began in September 2013 and was completed in February 2014.
Review of medical and social records was completed on April 30, 2014. Study
participants received $20 in cash and reimbursement or validation for parking and travel
costs. Participants were offered support from pediatric staff to access adult medical or
social services, if needed and desired.
Data Collection
Data to examine post-transition mortality (Aim 1) and engagement in HIV care
(Aim 2) and associated factors were abstracted from participant’s medical and social
records. Data were recorded on a standardized, de-identified, chart abstraction form
(Attachment 6). To asses if measures were clear and unambiguous and to be collected
information was available in existing data sources, the data collection instrument was
pre-tested using medical records of two deceased patients. Information was abstracted
from medical and social paper records (before 2010) and electronic records (UChart for
medical and CAREWare for sociodemographic information) thereafter. Specified post-
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transition clinical information of participants who transitioned outside of the University
Medical Center was requested by fax, accompanied by signed HIPAA (Authorization to
Use and Disclose Health Information) and Authorization of Health Information for 3rd
Party Disclosures forms.
Data to assess participants’ (post)-transition experiences (Aim 3) were collected
with a computer-assisted survey (Qualtrics), administered at the pediatric clinic. The
survey was followed by a de-briefing to allow participants to clarify or elaborate on their
answers. To improve quality, the survey instrument was pre-tested among six clinic
patients with PHIV who had transitioned less than one year ago, and, therefore, were not
eligible for study participation. Pre-test was conducted to examine if: (1) questions were
clear and understood as intended (validity), (2) participant burden was acceptable, and (3)
participants’ were at ease with the mode of survey administration. In general,
participants felt the survey was easy to understand and complete, asked the right
questions, and was not too long. A review of pre-test data showed participants needed on
average 24 minutes to complete the survey; all participants completed all questions, and
no inconsistent answers were observed. Nevertheless, in de-briefing to retrieve
participants’ reasoning processes using cognitive probes (e.g. “In your own words, what
do you think we wanted to know”, and “How did you decide to choose this answer”), it
became apparent that some questions needed to be revised.4 In addition, while the initial
survey had few open-ended questions to minimize participant burden, pre-test
participants requested to add more open-ended questions, to - as one participant worded“Have our voices heard.” The revised questionnaire was administered to participants.
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Measures
Measures to test study hypotheses of Aim 1 (Mortality) and Aim 2 (Engagement in
HIV care) are presented in Figure 2. Outcome variables differ; co-variates are the same.
Subsequently, quantitative and qualitative measures to assess transition experiences and
program recommendations (Aim 3) will be described.

Figure 2. Co-variates study aims 1 (assess post-transition mortality) & 2 (engagement in HIV care)

Outcome Variables Study Aims 1 & 2
Aim 1: To assess post-transition mortality. Primary outcome: death after transition.
Patient status was marked on a transition log, which was kept and updated by pediatric

30

staff. Participant status was marked as deceased if patients had died before April 30, 2014,
when data collection was completed.
Aim 2: To assess engagement in pediatric and adult HIV care. Primary outcome:
engagement in HIV care, defined as kept appointments with an HIV provider.
Engagement in HIV primary care is increasingly recognized as a crucial step in
maximizing patient outcomes.5 Participants’ last medical visit at the pediatric clinic was
recorded as the transition date. For patients who had dropped out of pediatric care, the
administrative transition date was their 24th birthday. For all participants, the number and
dates (m/y) of kept visits were abstracted for at least two observation periods: 12 months
before the patient’s transition date, and 12 months post-transition. Depending on patient
status and transition duration, we also captured the number of medical visits in the second
year post-transition.
A recent study comparing six different retention measures concluded that there is
no clear “gold standard” and advised to use multiple retention measurements.6 We
measured engagement in HIV care as: (1) the number of kept visits during a 12-month
observation period, and (2) visit constancy: proportions of participants attending at least
one primary care visit at 3-month [quarterly] intervals in a 12-month [four quarters]
observation period. We measured visit constancy, because retaining HIV-infected
patients in care at regular intervals results in better health outcomes.7 The 3-month
interval is based on pediatric clinic practices where patients were scheduled to see their
HIV provider quarterly for a routine appointment, consistent with national
recommendations.
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Co-variates
Patient characteristics. Information regarding patient characteristics, including
patient gender, race ethnicity, transmission category, transition date, and transition age
was abstracted from participants’ pediatric medical and social records. Racial, ethnic
(Black or African American, White, non-Hispanic or Hispanic) and birth country data
(US born or not) were collected because disparities were documented in risk of mortality
in HIV-infected persons in Florida 8,9 and engagement in HIV care.10 Participants’ gender
was recorded because of reported gender disparities in health care utilization and
medication adherence.10,11 Standardized information about patients’ mental health
status, substance abuse, and medication adherence was not available. Patient records did
include physician’s observations regarding these factors for some patients, which were
reported for deceased patients only.
Primary care history included markers of progression of HIV disease (CD4+ Tlymphocyte [CD4] count and quantitative HIV RNA plasma levels [“viral loads”]). For
all participants, CD4 count and viral load were abstracted for 2 periods: pre-transition
(most recent test results when participants transitioned and left pediatric care), and oneyear post transition. For participants who had transitioned two years or more ago, we also
abstracted two-year post transition information, as well as their most current information
e.g. most recent available test results). Frequency of hospital admissions in the year
before participants’ transition date were also recorded.
Social and economic factors. Social and economic factors included educational
attainment, household income, housing, employment status, and type of health insurance.
The most recent information at participant’s transition date was recorded. Educational
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attainment measured the highest level of education completed at time of transition, and
included the following categories: did not complete high school; high school or
equivalent; vocational/tech program after high school; college or university (some) or
unknown. The equivalent of obtaining a high school diploma was successfully passing
the General Education Development (GED) test; a terminal degree for those with
interrupted academic trajectories because of health or other problems.12 Employment at
transition assessed whether participants were (un)employed and/or enrolled in school;
more detailed information regarding type of employment, job security, if participants
worked full or part-time and other work-related characteristics that may impact health
were unavailable. Household income was abstracted using the following categories:
equal or below federal poverty level (FPL); 101-200% of FPL; 201-300% of FPL; 301400% of FPL; ≥ 401 of FPL, and unknown. Participants with a recorded household
income equal to or below the federal poverty level ($23,850 for a four-person US
household in 2014) were considered to live in poverty.13 Housing - in the last 12 months
pre-transition, most of the time- was measured using six categories, including homeless
(in the street, outdoors or shelter), moved around, lived in own or shared placed, with
(extended family), other (please explain), and unknown. Finally, enrollment in health
insurance (yes/no) when participants transitioned to adult HIV care was assessed in
different categories, measuring whether participants had obtained private or public
(Medicaid or Medicare) medical insurance or relied on Ryan White funding to cover their
healthcare costs.
Psychosocial factors. Psycho-social factors which may impact participants’ health
status included participant relationship status at time of transition (including: married, in
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relationship, but not married, single or unknown) and maternal vital status. Information
was obtained from the Ryan White Part D coordinator.
Exposure to the comprehensive transition program. To measure exposure to
transition program activities, the following information was abstracted: (1) participants’
transition date before 2008 or thereafter, when the comprehensive transition program was
funded and implemented, and (2) attendance of the transition clinic (including: preand/or post-transition clinic). Information about exposure of individual participants to
specific components of the transition program was incomplete. Therefore, with exception
of transition clinic attendance, the potential value of single program components could
not be assessed.
Transition Experiences and Program Recommendations (Aim 3)
Social-demographic and clinical measures. Social-demographic information,
including age, gender, race/ethnicity, educational level, household income below or
above poverty level [$24,250 for a four-person household in 2015],14 and transition date
were abstracted from participant’s pediatric records. To assess current circumstances, we
asked participants to answer questions about housing, family, and (any) employment
status, as well as gaps in medical insurance in the past 12 months. A measure of food
insecurity, “In the past year, were you ever worried whether food would run out before
you got money to buy more?” was used as a proxy measurement of current poverty.15
Data to describe engagement in adult HIV care were abstracted from the patient adult
medical records. Based on current HIV/AIDS performance measures, the expectation for
medical HIV care was at least one medical visit in a 6-month period in the past 12
months.16
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Participant experiences and program recommendations. This study incorporated
questions of a semi-structured transition telephone survey by Wiener and colleagues,
developed to describe transition barriers, as identified in earlier studies.17 Because this
study administered a computer-assisted survey to collect study data, we were able to ask
additional, more detailed (close- and open ended) questions. Figure 3 presents the
questions to assess participant’s exposure to and satisfaction with the transition program,
their experiences with transitioning and post-transition experiences, and their suggestions
for improvement of the transition program. After survey completion, the lead researcher
invited participants to clarify or elaborate on their survey answers in a short de-briefing
interview. Participant quotes were written down verbatim; observational notes were
completed directly after the interview.
Statistical Analysis
Analysis of quantitative data was performed using Epi Info 3.5.4 (Atlanta, GA,
2012). Univariate statistics (means, standard deviation [SD], medians, interquartile range
[IQR], and mode) were used to describe characteristics of the study population.
Continuous data (e.g. CD4+ T-lymphocyte [CD4] count and quantitative HIV RNA
plasma levels [“viral loads”]) were analyzed using the Kruskal-Wallis test for two groups
(alpha=0.05), which has no assumption of normal data distribution. Outcome variables
(e.g. mortality [Aim 1] and engagement in HIV care [Aim2]) and covariates were
dichotomized for inferential statistical analysis. The Fisher exact two-tail test
(alpha=0.05) was used to assess whether differences in categorical variables were
statistically significant. Risk ratios (RRs), as measures of relative risk, were calculated to
assess the strength of associations between potential predictors and primary outcome
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variables; 95% confidence intervals (CIs) were calculated to assess precision of RRs.
Stratified analyses were conducted to control for confounding and assess effect
modification, using Mantel-Haenszel (MH) RRs and 95% CIs and Fisher exact tests to
compare differences across strata for statistical significance.

Figure 3. Survey questions to assess transition experiences and suggestions for transition program
improvements

Qualitative information (Aim 3) included participant’s responses to open-ended
questions of the computer-assisted survey and participant’s verbatim quotes from a short
de-briefing interview. This information was systematically analyzed using the thematic
analysis method.18 Thematic analysis is an iterative process followed to remain true to
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participant’s description while developing more abstract concepts in various stages of
data analysis. Analysis was conducted manually, and included the following steps:
familiarization with data and repeatedly reading texts, generating initial codes, grouping
codes in different themes, and refinement and consideration of the meaning within and
across themes. In the final, exploratory phase, the analysis was discussed with a third
researcher to explore associations between core concepts and themes, established
literature, and theoretical perspectives related to transition experiences of PHIV young
adults. To minimize pre-conceived notions and potentially expand (alternative)
explanations, we conducted multiple coding by two different researchers. Both
researchers had HIV-related research experience, but not with PHIV adolescents or
young adults. To further minimize the risk of researcher bias and furnish alternate
interpretations, a third researcher, who had former clinical and research experience with
PHIV adolescents and young adults but had not been involved in the study design or data
collection, reviewed the analytic framework and data interpretation.
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What’s Known on This Subject
Transition from pediatric to adult care of perinatally HIV-infected young adults may
impact health, but post-transition mortality and associated factors have not been assessed
in North America.
What This Study Adds
When stratified by other factors, severe immunodeficiency, high school non-completion
and unemployment at time of transition were independently associated with mortality;
transition clinic attendance did not affect mortality.
ABSTRACT
Objective: To describe mortality in perinatally HIV-infected young adults after transition
to adult care and identify associated factors.
Methods: Patients who had transitioned from a pediatric outpatient clinic to adult HIV
care between January 2003 and September 2012 were recruited for a retrospective cohort
study, completed on April 30, 2014. The main study outcome was post-transition death.
The most recent clinical and social-demographic data before transition were abstracted
from medical and social records.
Results: Of 51 transitioned patients, nine (18%) had died, all of HIV-related causes,
most (5 [56%]) in the first year post-transition. Of 42 survivors, 33 were eligible; 27
(82%) provided consent. Immunosuppression (CD4+ T-lymphocyte [CD4] count <100
cells per μL) at transition was associated with a six-fold higher risk of mortality (67% vs.
11% in patients with CD4 count >100 cells perμL; relative risk [RR] =6.0, 95% CI=1.8819.19 [P=.005]). When controlled for CD4 count, employment at time of transition was
associated with an almost 80% reduction in mortality risk (MH adjusted RR= 0.19; 95%
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CI=0.04-0.88 [P=.02]), and GED/high school non-completion with three times higher
risk of death (MH adjusted RR= 2.97; 95% CI=1.37-6.40 [P=.07]). All patients who died
(9) had a viral load > 1000 copies/ml; all deaths occurred in patients who had CD4 count
<100 cells per μL (6) or lived in poverty (3). When controlled for CD4 count and poverty,
mortality was identical among transition clinic attenders and non-attenders.
Conclusions: Transition was associated with high mortality, particularly in patients who
were severely immunosuppressed, unemployed or less educated at time of transition.
Comprehensive programs should focus on improvements in clinical care and include
academic and employment services.
INTRODUCTION
Mortality in perinatally HIV-infected (PHIV) children has declined considerably
since the introduction of combination antiretroviral therapy (cART) during the late
1990’s.1,2 In the United States (US), the pediatric HIV population consists of a relatively
stable group3 of approximately 10,000 infected children, adolescents, and young adults,
with the addition of < 100 newly infected infants born annually.4 Most children who have
access to cART now survive into adulthood, “age out” of pediatric care, and transition to
adult medical care.5
A successful transition is regarded as a key aspect in maintaining health in this
population.6,7 Recent State-of -the-Art articles describe a shared concern that transition
may have adverse health effects, because vulnerable young PHIV adults will need to
navigate the adult care system independently after leaving behind the familiar
surroundings and comprehensive services available in most pediatric care settings.8,9 To
date, however, little is known about clinical outcomes of PHIV young adults as few
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pediatric or adolescent clinics track their patients after transition.10-12 As far as we know,
post-transition mortality has been assessed in England and Ireland, but not yet in the
United States.13
There is a critical need to follow-up on transitioned PHIV adults to ensure that
therapeutic successes of earlier decades continue to benefit them and to contribute to
evidence-based transition practices, which may support young adults who will soon
transition.14 The purpose of our study was to describe post-transition mortality and
identify clinical and socio-demographic factors, including attendance at a transition clinic
to facilitate adjustment to adult care, which may affect the risk of death after transition to
adult HIV care, in a US cohort of PHIV young adults.
METHODS
Study Design
We conducted a single-center, retrospective cohort study consisting of analysis of
data of patients who transitioned to adult medical care from a university-based pediatric
clinic in Florida in the Southeastern US. The clinic provides comprehensive HIV services
to children, adolescents, and young adults up to age 24 who acquired HIV early in life,
nearly all through vertical transmission. The clinic’s family-centered, comprehensive
HIV services include case management, nursing, nutrition, neurodevelopmental
assessment, mental health, and peer education and support, and is largely funded by the
US Health Resources and Services Administration Ryan White Part D grant programs.
Study approval was obtained from the authors’ ‘parent institutions’ institutional review
boards.
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Selection and Recruitment of Participants
Patients were eligible for study participation if they had transitioned from the
pediatric clinic to adult care between January 2003 and September 2012. Records of
known deceased patients were reviewed. Living patients were excluded from study
participation if they were unable to provide valid informed consent for clinical record
review due to: (a) severe cognitive disability, as was previously determined by staff
psychologists in pediatric HIV care, (b) incarceration, or (c) relocation. Most transitioned
patients had stayed in contact with pediatric clinic staff or with each other and were
recruited by telephone or in person. Informed consent was obtained by a research staff
member who had not been involved in previous care. All living participants were able to
read and understand English, were older than 18 years of age, and had signed informed
consent and Health Insurance Portability and Accountability Act (HIPAA) patient forms
at the clinic site before collection of de-identified data. Participants who were not
receiving medical care or other needed services were offered support by pediatric clinic
staff to access services. Study participants received $20 and were reimbursed for travel
and parking costs. Participant enrollment started in September 2013 and was completed
in March 2014. Data collection was completed on April 30, 2014.
Data Collection and Measures
The main outcome was death after transition, confirmed by medical record review
or information recorded by the pediatric clinic coordinator. Clinical, laboratory, and
sociodemographic information included the most recent information available before
transition to adult medical care. Researchers reviewed decedent and living study
participants’ pediatric clinic medical and psychosocial services records to abstract the
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following information on a de-identified standardized form: primary care history
(transition date, age at transition); demographic characteristics (birth year, gender, age at
transition, HIV transmission category, race/ethnicity, foreign birth, educational
attainment, housing status, household income, employment status, and type of health
insurance), and psychosocial resources (relationship and family status). Racial, ethnic and
birthplace data were collected because striking disparities by these factors have been
documented in risk of mortality in HIV-infected persons in Florida.15,16 Abstracted
sociodemographic information was reviewed and validated by the pediatric clinic
coordinator. Clinical information included markers of progression of HIV disease and
response to ART (CD4+ T-lymphocyte [CD4] counts and quantitative HIV RNA plasma
levels [“viral loads”]. Primary care history data included exposure to the comprehensive
transition program (transitioned before 2008 or later when a formal transition program
was implemented), and attendance of the pre- or post-transition clinic (see below).
Objective, standardized, measures of ART adherence and substance use were
unavailable; comments in progress notes were selected to describe clinician’s
impressions.
Transition Program
In 2008, a formal comprehensive transition program was funded and implemented
to address high attrition rates and to prepare patients for successful transition to adult
HIV care. Program components included services to prepare patients for independent
living (including educational and vocational support), increase self-management skills
(including “life skills” and support groups), and “bridge” pediatric and adult HIV care
(including discussion of transition plans, provision of linkages to adult services, and
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availability of a transition clinic). Pediatric patients, primarily those who may have
needed additional transition support, were referred to the transition clinic by pediatric
staff. In the last year pre-transition, patients were seen by an adult physician for at least
one routine appointment at the pediatric clinic (pre-transition clinic).17 In the first year
post-transition, patients were seen by the same adult physician, with whom they had
started to build a relationship and who had more time allotted for a routine visit, in the
adult HIV clinic of the nearby public hospital (post-transition clinic). For one year posttransition, support was also provided by the pediatric transition social worker.
Statistical Analysis
Analysis was performed using Epi Info 3.5.4 (Atlanta, GA, 2012). Univariate
statistics (means, standard deviation [SD], medians, interquartile ranges and proportions)
were used to describe characteristics of the study population. Continuous data were
analyzed using the Kruskal-Wallis test for two groups (alpha=0.05), which has no
assumption of normal data distribution. Covariates were dichotomized for inferential
statistical analysis. The Fisher exact two-tail test (alpha=0.05) was used to determine
whether differences in categorical variables were statistically significant. Risk ratios
(RRs), as measures of relative risk, were calculated to assess the strength of associations
between potential predictors and mortality, and 95% confidence intervals (CIs) were
calculated to assess precision of RRs. Stratified analyses were conducted to control for
confounding and assess effect modification, using Mantel-Haenszel (MH) RRs and 95%
CIs and Fisher exact tests to compare differences across strata for statistical significance.
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RESULTS
A total of 51 patients transitioned from the pediatric clinic to adult medical care
between January 2003 and September 2012. Nine (18%) had died by April 30, 2014,
when data collection was completed. All had died of HIV-related causes. Five (56%)
patients died within a year of their last pediatric clinic visit. Median survival time among
decedents was 195 days (range 13-2142 days). None of the nine decedents were virally
suppressed at time of transition and all had adherence issues (Table 3.1). Of the surviving
42 patients, nine were excluded from recruitment for consenting because of severe
cognitive impairment (3), incarceration (1), or residence outside of the county and
inability to come to the clinic to provide informed consent (5). Of the 33 eligible to
consent to medical record review, one was lost to follow-up, five declined participation,
and 27 (82%) consented. The total study population for this analysis consisted of 36
transitioned patients of whom nine had died since their transition to adult care.
Study participants were African-American/Haitian (83%) or Hispanic (17%)
(Table 3.2). Only 17% were foreign-born. Almost half (47%) lived in poverty with
household incomes equal to or below the federal poverty level ($23,850 for a four-person
US household in 2014).18 Most were known to have been infected by vertical
transmission (94%); one participant was infected by transfusion in the perinatal period
and one by sexual abuse. Most participants transitioned to adult HIV care at age 24; in
2008 or later when a formal comprehensive transition program was funded and
implemented. Pre-transition CD4 count were less than 200 cells/μL in almost half (47%)
of the study population; median CD4 count was 381cells/μL, and was lower for males
(144; range 7-722 cells/μL) than females (386; range 12-831 cells/μL ; P=.06). Similarly,
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median viral load in males (16,708; range 40-4,870,720 copies/ml) was higher than in
females (318; range 28-500,000 copies/ml; P=.09).
Risk of post-transition mortality did not differ significantly by gender, race,
ethnicity or foreign birth (Table 3.3). Household income, type of health insurance,
whether s/he was in a relationship and if his/her mother was deceased were also not
associated with a significantly different risk of mortality. Mortality risk was somewhat
lower among participants who transitioned before 2008 (when no formal transition
support program was available), and was almost twice as high among those who ever had
attended the transition clinic, although neither of these differences achieved statistical
significance. Those who had severe immunosuppression (CD4 count <100 cells/μL, viral
loads >1000 copies/ml) pre-transition were significantly more likely to have died. Pretransition viral loads were higher in decedents (median=83,800 copies/ml; IQR=15,416238,581 copies/ml) than in survivors (median=328 copies/ml; IQR=127-18,000
copies/ml; P<.001). Conversely, employment was associated with a significant reduction
in mortality. Completion of high school/General Educational Development test (GED)
requirements was also associated with a reduction of mortality risk.
Stratified analysis controlling for CD4 count affected the strength of associations
between non-completion of high school/GED and mortality and employment and
mortality (Supplemental Table 3.4). Low CD4 counts (<100 cells/μL) confounded the
association between employment and mortality, weakening somewhat the protective
effect of employment. When controlled for CD4 count, employment at time of transition
was associated with almost 80% reduction in mortality risk (MH adjusted RR= 0.19; 95%
CI=0.0-0.9, P=.02); GED/high school non-completion was associated with three times
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higher risk of death (MH adjusted RR= 2.97; 95% CI=1.4-6.4, P=.07). Patients living in
poverty (income below FPL) or who had CD4 counts <100 cells per μL were more likely
to die than others; all decedents had either a CD4 count < 100/ µl (6) or household
income below poverty level (3). All nine deaths occurred in the 21 (43%) who had CD4
counts <100 cells or lived in severe poverty (vs. 0 of 15 patients neither living in poverty
nor severely immunosuppressed [0%]; P=.006). Participants with these characteristics
were also more likely to have attended the transition clinic (14/21 [67%] vs. 5/15 [33%];
RR=2.0; 95%CI=.92-4.4, P=.10). When the analysis was confined to participants who
had a CD4 count <100 cells/μL and who lived in poverty, risk of death was identical in
transition clinic attenders and non-attenders [42.9%].
DISCUSSION
These data suggest a very high post-transition risk of mortality; of 51 patients
who transitioned between January 2003 and September 2012, nine (18%) patients died
after transition, most within one year, all of HIV-related causes. In the study population
(36 participants of whom nine decedents and 27 who were eligible and consenting),
factors significantly associated with mortality were advanced immunosuppression, poor
viral suppression, unemployment, and high school/GED non-completion at time of
transition. Most participants were US-born African-Americans or Haitians, reflecting the
striking health disparities in perinatal HIV transmission in the United States.19 Social
disadvantages were evidenced by the high proportion of patients living in poverty and
who relied on Medicaid or Ryan White insurance for their health care costs. Transition
clinic participation seemed to have been preferentially recommended to patients living in
extreme poverty or with severe immunosuppression; when controlled for these factors,
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mortality risk was identical among transition clinic attenders and non-attenders,
suggesting that this intervention did not impact mortality.
At transition, 25 out of 36 (69%) participants had CD4 counts <500 cells/μL,
which was not unexpected as the young adults in our study acquired HIV before the
development of their immune system, and before highly effective treatment became
available in the late1990s; many PHIV patients have complex clinical histories and
possibly HIV antiretroviral drug-resistant virus, complicating their care and limiting the
choice of therapy.1,5,14 Treatment may have been further complicated by cognitive,
developmental, and psychosocial challenges exacerbating difficulties adhering to lifelong
therapies.20
Several studies have documented poor health outcomes among HIV-infected
adolescents and young adults in adult HIV care.12,21,22 As far as we know, only one study
conducted in England and Ireland (United Kingdom [UK]) assessed mortality after
transition to adult care.13 That audit of 14 adult clinics caring for 248 transitioned PHIV
reported 11 deaths (4%) between September 2003 and March 2011, with seven deaths
directly related to HIV-progression. Compared to our study in a similar time period, UK
patients transitioned at an earlier age (median 17 versus 23 years in our cohort), were less
likely to die (11/248 [4%] versus 9/51[18%]), and had a longer post-transition survival
time. The increased post-transition survival in UK PHIV adolescents and young adults
may suggest a bias towards earlier death among our participants due to the longer
duration of life with HIV infection at time of transition. Differences between health
systems and social policies suggest additional explanations: the UK reports far superior
retention in HIV care and viral suppression,23 while outcomes are particularly poor in
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Florida for African-Americans and Hispanics.15,16 US patients on public insurance may
be vulnerable to gaps in health insurance,24 whereas the UK National Health Service
covers all citizens and is comparatively easier to navigate.25 Differences in social services
expenditures also may be of importance in explaining differential health outcomes.
Expenditures on social services, including housing, employment training, unemployment
benefits and family support which have been found to be associated with improved
outcomes, are proportionally higher in the UK, whereas the US allocates most health
resources to health care.26
The impact of social determinants on health is well documented.27,28 In our study,
GED/high school non-completion and unemployment were associated with posttransition mortality, particularly in patients who were not severely immunosuppressed.
Lower educational attainment has been found to be associated with increased mortality,
with substantial benefits of high school completion, especially for US AfricanAmericans.29 Several studies have shown associations between employment status and
health among HIV-infected people.30,31 In our study, however, employment may also
have been partially a marker for health, despite its independence of immune status. With
few exceptions, studies show that “the lower an individual’s socioeconomic position the
worse their health.” 27 p.1153 Study findings suggested that poverty impacted mortality,
although the small sample size precluded definite conclusions.
Our study is a preliminary exploration of mortality and associated factors among
transitioned PHIV. One of the strengths of this study is the long duration of follow-up.
Limitations include the small sample size and reduced power to detect statistically
significant differences despite large effect sizes, ineligibility or non-participation of 15
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living patients, and the retrospective nature of our study. We could not entirely discard
the possibility that employment and education were markers of levels of health or social
disorganization. Because of the poor health status of deceased patients at transition, it is
unclear whether transition itself had negatively impacted the disease course. Because our
study was conducted at a single site, generalizability of study findings may be limited.
Despite these limitations, our study supports American Academy of Pediatrics
guidelines suggesting that transition planning start early in adolescence and should ensure
comprehensive care addressing physical health, and social, psychological, educational,
and vocational needs.6 As PHIV youth mature, they encounter daunting challenges in
managing their HIV disease while obtaining education and employment. Comprehensive
services should support youth to complete high school, obtain employment, and escape
poverty. Clearly, transition of young adults who are severely immunosuppressed requires
extreme caution; it may be prudent to provide ample resources to enable pediatric clinics
to provide intensive support to improve patients’ immune status and viral responses to
antiretroviral therapy before transition. Finally, in Florida, where mortality among adult
African-American and Hispanic HIV patients is considerably higher than in White
counterparts and mortality elsewhere in the United States, supportive, comprehensive,
family-centered coordinated care typical of pediatric clinics should be considered even
for adults instead of prioritizing preparation of pediatric patients to adjust to the less
supportive services of adult care.32
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Table 3.1. Characteristics of perinatally HIV-infected young adults at transition who died post-transition.
#

Gender Race/Ethnicity

Transition Transition
year
age
(years)

CD4
Viral load Hospital
count
(copies/ml) Admissions
(cells/µl)
12 months
pretransition
(days/times)

Survival Pediatric clinical
time
notes
(days)

1

female

Haitian

2004

18

143

83,800

unavailable

2,142

2

female

Hispanic

2007

19

12

500,000

63 (6)

152

3

male

Haitian

2008

23

<20

33,400

5 (1)

1,167

4

female

African-American

2010

24

157

1,613

12 (2)

1,614

5

female

African-American

2010

22

157

210,812

86 (13)

83

6

male

African-American

2011

23

<20

15,416

49 (5)

13

7

male

African-American

2012

23

<20

4,870,720

142 (15)

195

8

male

African-American

2012

23

<20

11,437

15 (2)

180

male

Haitian

2012

24

<20

238,581

32 (3)

413
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“Unwilling to take
meds. Does not
want to discuss it.”
“Multi-drug use.”
“Extremely noncompliant.”
“Does not keep his
appointments.”
“Could not
understand viral
loads and explain
it.”
“Multi-drug use.”
“Does not keep
appointments.”
“Huge compliance
issues.”
“Chronic noncompliance.”
“Patient is not
motivated to get any
treatment.”
“Does not believe
he has the virus.”
“Huge resentment
toward mother.”

Table 3.2. Sociodemographic and clinical characteristics at time of transition (N=36)
Characteristic

Overall
(n/%)

Female
Race/Ethnicity
African American
Haitian
Hispanic

18 (50)
18 (50)
12 (33)
6 (17)

Foreign born

6 (17)

HIV transmission route
Mother-to-child
Blood products
Sexual (abuse)
Mother deceased

34 (94)
1 (3)
1 (3)
30 (83)

Married/in relationship

15 (42)

Completed high school/GED

29 (81)

Employment (full or part-time)

20 (56)

Housing
Unstable
With (extended) family
Own or shared

2 (6)
18 (50)
16 (44)

Household income
Equal or below Federal Poverty Level (FPL)
101-200% FPL
201-400% FPL
Health Insurance
Medicaid
Ryan White
Medicare
Private
No insurance
Age (years) at transition
Mean:
Median
Mode
Transitioned in or after 2008
Attended Transition Clinic
CD4+ T-lymphocyte count (cells/L)
<100
100-<200
200-499
≥ 500

17 (47)
12 (33)
7 (20)
25 (69)
7 (19)
1 (3)
2 (6)
1 (3)
23 (SD1.7)
23 (18-26)
24
26 (72)
19 (53)
9 (25)
8 (22)
8 (22)
11 (31)
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Table 3.3. Factors associated with death (n=9) after transition to adult care (N=36)
Characteristics at time of
transition
Gender
Male
Female
Race
African-American or Haitian
Hispanic
Birth Country
Foreign-born
US-born
Relationship status
Married/in relationship
Single
Educational attainment
Less than High School/GED
High school/GED
Employment status
Employed
Unemployed
Household income
Below Federal Poverty Level
At or above Federal Poverty Level
Medicaid status
Medicaid insured
Not Medicaid insured
Maternal vital status
Mother deceased
Mother alive
Transition time period
Before 2008
In or after 2008
Transition clinic attendance
Attended transition clinic
Did not attend transition clinic
Viral load
>1000 copies/ml
≤1000 copies/ml
CD4+ T-lymphocyte count category
<100 cells/μL
≥100 cells/μL
ͣ Fisher exact two-tailed test

Died
# (/%)

Total

Risk ratio
(95% C.I.)

P value ͣ

5 (28)
4 (22)

18
18

1.25 (0.40,3.91)

>0.99

8 (27)
1 (17)

30
6

1.6 (0.24, 10.54)

>0.99

1 (17)
8 (27)

6
30

0.63 (0.09,4.12)

>0.99

4 (27)
5 (24)

15
21

1.12 (0.36,3.49)

>0.99

4 (57)
5 (17)

7
29

3.31 (1.19,9.22)

0.10

1 (5)
8 (50)

20
16

0.1 (0.01,0.72)

.006**

6 (35)
3 (16)

17
19

2.2 (0.66,7.58)

0.34

8 (32)
1 (9)

25
11

3.5 (0.50,24.84)

0.30

6 (20)
3 (50)

30
6

0.4 (0.14,1.17)

0.30

2 (20)
7 (27)

10
26

0.7 (0.18,2.99)

>0.99

6 (32)
3 (18)

19
17

1.8 (0.53.6.07)

0.56

9 (43)
0

21
15

-----

.006**

6 (67)
3 (11)

9
27

6.0 (1.88,19.19)

.005**

58

Supplemental Tables 3.4. Characteristics at transition associated with death posttransition, controlled for: a.) CD4+ T-lymphocyte count <100 cells per 𝛍𝐋 and b.)
CD4+ T-lymphocyte count <100 cells per 𝛍𝐋 and living in poverty
a.) CD4+ T-lymphocyte count < 100 cells per 𝛍𝐋
Characteristic
Employed
Unemployed

Number who Died (%)

Relative Risk
(95% CI)*

P-value†

1/3 (33.3)
5/6 (83.3)

.40
(.08-2.06)

.45

Number who Died (%)

Relative Risk
(95% CI)*

P-value†

0/17 (0)
3/10 (30)

0
----

.08

CD4+ T-lymphocyte count > 100 cells per 𝛍𝐋
Characteristic
Employed
Unemployed

Adjusted
Mantel-Haenszel
Relative Risk
(95% CI)*

P-value†

.19
(.04-.88)

.02

CD4+ T-lymphocyte count < 100 cells per 𝛍𝐋
Characteristic
High School noncompleter
High School graduate

Number who Died (%)

Relative Risk
(95% CI)*

P-value†

2/2 (0)

1.8

.83

4/7 (57.1)

(.92-3.32)

CD4+ T-lymphocyte count > 100 cells per 𝛍𝐋
ART
High School noncompleter
High School graduate

Number who Died (%)

Relative Risk
(95% CI)*

2/5 (40)

8.8

1/22 (4.5)

(.98-79.05)
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P-value†
.16

Adjusted
Mantel-Haenszel
Relative Risk
(95% CI)*

P-value†

2.97
(1.37-6.40)

.07

b) CD4+ T-lymphocyte count < 100 cells per 𝛍𝐋 and living in poverty
Characteristic
Transition Clinic
Attendance
Non-Attender

Number who Died (%)

Relative Risk
(95% CI)*

P-value†

6/14 (42.9)

1.0

>0.99

3/7 (42.9)

(.35-2.9)

CD4+ T-lymphocyte count > 100 cells and not living in poverty
Characteristic
Transition Clinic
Attendance
Non-Attender

Number who Died (%)

Relative Risk
(95% CI)*

P-value†

0/5 (0)

0

>0.99

0/10 (0)

(0-?)
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Adjusted
Mantel-Haenszel
Relative Risk
(95% CI)*

P-value†

----

----
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Summary statement:
Transition to adult HIV care may lead to poorer health outcomes, but few studies have
examined the effect of transition and programs to improve post-transition outcomes. This
study of transitioned perinatally HIV-infected young adults provides information about
post-transition engagement in adult HIV care and assesses the effectiveness of a
transition program.
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ABSTRACT
Purpose: To examine changes in HIV care engagement post-transition and identify
associated factors.
Methods: We conducted a longitudinal, retrospective cohort study of perinatally HIVinfected patients who transitioned from a pediatric clinic in the Southeastern US to adult
HIV care between January 2003 and September 2012. We assessed differences in the
number of kept appointments and visit constancy (at least one quarterly visit) in 3 years
(one year pre-transition and two years post-transition). We examined associations
between clinical and sociodemographic characteristics, including exposure to transition
program activities, and frequent care engagement in the first year post-transition.
Stratified analysis controlled for confounding.
Results: Of 31 eligible and consenting participants, we could obtain medical records of
25 participants for both the last pre-transition and first post-transition years. Participants
kept over twice as many appointments in the last pre-transition year than the first posttransition year (Median = 5, IQR 4-6 versus Median = 2, IQR 1-10; P=.002). In the first
year post-transition, the proportion of poorly engaged participants increased from one out
of 30 (3%) in pediatric to nine out of 26 (35%) in adult HIV care (P= .006), while the
proportion of frequently engaged participants decreased from 24 out of 30 (80%) in
pediatric to eight out of 26 (30%) in adult HIV care (P<.001). No significant changes
were observed between the first and second post-transition year. Patients who were
African-American or Haitian (19%) or low-income (8%) were less likely to have kept
frequent appointments than others (80%, P=.04; 50%, P=.06, respectively) in the first
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year post-transition. Engagement in adult HIV care was not significantly associated with
participation in a clinic transition program.
Conclusions: Care engagement decreased after transition to adult HIV care. Effective
interventions to support transition to welcoming, high-quality adult HIV services are
urgently needed.
INTRODUCTION
Advances in HIV care and treatment, specifically the introduction of combined
antiretroviral therapy (ART), have greatly increased life-expectancy of children HIVinfected in early life.1 As the prognosis has improved, an increasing number of
perinatally HIV-infected (PHIV) children will “age out” of pediatric or adolescent care
and transition to adult care services.2 Concerns have arisen about whether therapeutic
successes of earlier decades will continue to benefit PHIV young adults after transition.3
Continuous care is essential for all patients on ART as even short lapses in treatment may
have significant consequences for viral suppression, drug resistance, and HIV
transmission.4 Successful transition to adult care services may be more critical for PHIV
patients. Many will be in advanced stages of HIV-disease having longer and more
complex medical histories than their behaviorally infected counterparts, leading to
complicated treatment and limited therapy options.5
Transition experiences and outcomes are context-dependent and may vary
according to policies and health systems.6 In the US, transition may be particularly
challenging, in part because of fundamental differences between pediatric and adult
medical care settings.7,8 In general, most pediatric patients have longstanding
relationships with their HIV provider and receive comprehensive “one-stop shopping”
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medical and psychosocial services in a welcoming and familiar environment. In contrast,
adult care services tend to be less accommodating and more impersonal, requiring
patients to independently navigate health and social services and self-manage their
chronic conditions. PHIV young adults may not have the functional autonomy presumed
in adult HIV care.9 PHIV children in the US are disproportionally members of ethnic
minority groups living in underserved urban areas, burdened by psychosocial issues,
including poverty and HIV stigma, which may further complicate transition.10 These
issues may be exacerbated by the complexity of the US healthcare system,11 and the
under-resourced, stressed system of HIV care for patients who depend on public health
insurance.12
To date, most transition studies have been qualitative and described barriers to
transition from the perspectives of pre-transition youth, their caregivers and providers.13
The few studies of young adults post-transition found considerable challenges and barriers
to accessing adult HIV care and supportive services.14,15 A recent retrospective study of
transitioned patients with behavioral and perinatally-acquired HIV concluded that the
health care transition process needs to be optimized as only 50% of patients were retained
in adult HIV care one year post-transition, and had completed at least two clinical visits.16
Cross-sectional studies documented poorer health outcomes in patients in adult HIV care
compared to their peers in pediatric care,17,18 and to HIV-infected adult patients.19 A recent
study reported prolonged poor engagement in adult HIV care extending from adolescence
through young adulthood (25-34 years old).20 Loss-to-follow-up among HIV-infected
youth was found to be associated with receiving care at adult clinical settings.21
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Acknowledging the risk of poor transition outcomes, transition services and
programs are increasingly recognized as key components of pediatric or adolescent care.3,22
Although many clinics have implemented programs to prepare and support transition in
PHIV young adults, few empirical data exist to guide these programs. 13,23 This study
assessed engagement in HIV care one and two years after PHIV patients transitioned from
a comprehensive pediatric treatment program in the Southeastern US to adult care,
exploring the role of various factors, including exposure to a transition program, in posttransition engagement in care.
METHODS
We conducted a longitudinal retrospective study of patients who had transitioned
to adult medical care from a university-based pediatric HIV clinic in the southeastern
United States. The clinic provides outpatient comprehensive services to low-income and
underserved children, adolescents and young adults through 24 years in age who acquired
HIV early in life, nearly all through vertical transmission. Since 2008, the clinic has
implemented a comprehensive transition program, largely supported by Ryan White
funding. Available interventions included support from medical and psychosocial staff,
educational workshops, support groups, peer and individual counseling, attendance of a
transition clinic and follow-up by a transition social worker in the first year posttransition. The transition clinic is a collaborative effort between pediatric and adult
services to address post-transition attrition.24 To bridge the gap between pediatric and
adult care, pediatric patients could be referred to an adult provider for one or more
quarterly appointments, which were held at the pediatric clinic site in the last pretransition year. In the first year post-transition, transitioned patients could schedule
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appointments with the now familiar adult provider at the academic center’s adult HIV
clinic, who allots more than the traditional 15-minutes for a routine medical visit. In the
second year post-transition, no transition services were provided.
Participants
Patients were eligible for study participation if they had transitioned from the
pediatric clinic to adult medical HIV care settings between January 2003 and September
2012. Living patients were excluded from study participation if they were unable to
provide valid informed consent in person because of severe cognitive disability (as
determined by staff psychologists during routine neuropsychological testing while in
pediatric HIV care), incarceration, or relocation. Because we collected follow-up
information for at least one year after transition, patients who died within one year of
their transition date were also excluded.
Procedures
Approval for the study protocol was granted by the institutional review boards of
relevant institutions. Former patients were contacted by phone or in person, as many
maintained contact with pediatric clinic staff or their peers. Those interested in
participating provided written informed consent at the clinic, and authorized disclosure
and use of health information for study purposes. Consent was obtained by a researcher
who had not been involved in the participants’ previous care. After providing informed
consent, participants completed a computer-assisted (Qualtrics) questionnaire about their
transition experiences. Sociodemographic and clinical data were abstracted from
patients’ medical and social records using an abstraction form, without personal
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identifiers. Sociodemographic information was reviewed and validated by the transition
coordinator.
Participants were recruited from September 2013 to February 2014. Data
collection was completed on April 30, 2014. Study participants received $20 and were
reimbursed for travel and parking costs. All participants were offered support from
pediatric staff to re-engage in adult medical or social services, if needed and desired.
Measures
The primary outcome variable was engagement in medical HIV care, defined by
the number of kept appointments. Participants’ last medical visit at the pediatric clinic
was recorded as the transition date. For all participants, the number of kept medical visits
as recorded in medical records was abstracted for at least two observation periods: 12
months before the patient’s transition date, and 12 months post-transition. Depending on
transition date and patient status, we also captured the number of medical visits in the
second year in adult HIV care. Research suggested using multiple retention
measurements.25 We measured engagement in HIV care as: (1) the number of kept visits
during a 12-month observation period, and (2) “visit constancy” (proportions of
participants attending at least one primary care visit at 3-month [quarterly] intervals in a
12-month [four quarters] observation period). Patients were categorized as having had at
least one kept visit with an HIV provider in 4,3,2,1 or 0 quarters. We measured visit
constancy, because retaining HIV-infected patients in care at regular intervals results in
better health outcomes.26 The 3-month interval is based on pediatric clinic practices
where patients were scheduled to see their HIV provider quarterly for a routine
appointment,22 which reduces the risk of exhausting the supply of anti-retrovirals (usually
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prescribed for three months) and facilitates early detection of emergence of resistance. To
assess factors associated with frequent care engagement in the first year post-transition,
we assigned patients to two groups: regularly engaged (kept at least one medical
appointment in each of the 3 or 4 quarters) and not regularly engaged (did not keep at
least one appointment in each 3 or 4 quarters).
Transition Program Effectiveness
To assess the effects of the transition program, we examined if exposure to the
comprehensive transition program (transitioned in 2008 or thereafter) and attendance of
the pre- and/or post-transition clinic (at least one kept appointment) were associated with
regular care engagement in the first year post-transition (at least one kept appointment in
three or four quarters). Information about transition clinic attendance was derived from
data abstracted from medical records. Participants reported their satisfaction with the
transition clinic in a computer-based survey. Systematic records of follow-up contacts
with the pediatric transition social worker in the first year post-transition were not kept.
Patient Characteristics
Collected clinical and sociodemographic information included the most recent
information before transition to adult medical care. Study participants’ pediatric medical
and social records were reviewed to abstract the following information: primary care
history (including: transition date, age and CD4 count, viral load); demographic data
(including: gender, HIV transmission category, race/ethnicity, educational attainment,
household income, housing and employment status, type of health insurance), and
psychosocial resources (including: relationship and family status). Mental health and
substance use information was incomplete and not included.
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Analysis
Analysis was performed using Epi Info 3.5.4 (Atlanta, GA, 2012). Univariate
statistics (medians, interquartile range [IQR], and mode) were used to describe
characteristics of the study population. The Kruskal-Wallis test for two groups, which has
no assumption of normality, was used to compare numbers of kept HIV appointments and
assess significance of differences between the three observation periods (pre-transition,
and one-and two-years post-transition). Outcome variables and covariates were
dichotomized for inferential statistical analysis. Significance testing for categorical
variables was conducted using the Fisher exact two-tailed test (alpha=0.05). Stratified
analysis was conducted to control for confounding. Prevalence ratios (crude and MantelHaenszel adjusted RRs) were calculated to assess the strength of associations; the 95%
confidence interval (CIs) interval was calculated to assess precision of estimates.
RESULTS
Between January 2003, and September 2012, 51 patients transitioned from the
pediatric clinic to adult medical HIV care settings. Of these, nine patients (18%) were not
eligible for study participation because of cognitive impairment (3), incarceration (1), or
relocation (5). Nine patients (18%) were deceased when data collection was completed;
five died within one year of care transfer and were not included in this study; four were
included. Of the 33 eligible patients who were alive at time of data collection, 27 (82%)
agreed to participate. Reasons for refusal were not ascertained. The total study population
consisted of 31 patients (including 27 who agreed to participate and four who died after
the first post-transition year).
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All study participants were members of racial or ethnic minority populations,
including African-Americans/Haitians (84%) or Hispanics (16%) [Table 4.1]. Nearly half
lived in extreme poverty, with household incomes equal to or below the federal poverty
level. At transition, most participants had completed high school or had passed the
General Education Development (GED) test, were employed, and housed. All but one
had health insurance, and most relied on public insurance or Ryan White to cover their
health care costs. The last available CD4 count at the pediatric clinic showed severe
immunosuppression (CD4 count < 200 cells/mm³) in over one-third of the study
population. The median CD4 count was 333 cells/ mm³ (range 7-831 cells/ mm³).
Median viral load was 1,613 copies/ml (range 28-238,581 copies/ml).
Most participants had transitioned at age 24; 22 out of 31(71%) participants
transitioned in 2008 or thereafter, when the comprehensive transition program was
implemented. Sixteen (52%) study participants had ever attended the transition clinic;
most (63%) had attended both the pre-and post-transition clinic. Of 13 attendants alive at
the time of data collection, less than half (47%) reported they felt the transition clinic had
been “very” or “quite” helpful to transition successfully.
The median number of kept HIV, specialty-care, appointments decreased
significantly in the first year in adult HIV care (Table 4.2). Participants kept more than
twice as many appointments in the last year in pediatric care as in the first year posttransition (median=5, interquartile range (IQR) = 4-6 appointments versus median = 2,
IQR = 1-10 appointments; P=.002). The median number of appointments increased in the
second year post-transition, but this increase was not significant. Trends were similar for
visit constancy (Table 4.3). The proportion of poorly engaged participants significantly
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increased from 3% in pediatric care to 35% in the first year post-transition (P=.006),
while the proportion of regularly engaged participants significantly decreased from 80%
in pediatric care to 30% in the first year post-transition (P <.001). No significant changes
were observed between the first and second year post-transition.
The likelihood of regular engagement in the first year post-transition did not vary
significantly by relationship status, educational achievement, employment status, housing
arrangements, type of insurance, or health status (Table 4.4). However, non-Hispanic
black participants or those who lived in extreme poverty at transition were considerably
less likely to be engaged in regular HIV care (P=.04, P=.06, respectively). These
associations were also observed in the last pre-transition year at the pediatric clinic, but
there, the differences did not approach statistical significance (P=.38; P=.65,
respectively). Participants who transitioned in or after 2008 were only slightly more
likely to be regularly engaged in adult health care compared to those who transitioned
before 2008 (33% versus 20.0%, respectively; P=>.99). Overall, participants who
attended the transition clinic were less likely to see their HIV provider regularly one year
post-transition. However, participants living in extreme poverty were significantly more
likely to have attended the transition clinic (10/12 [83%) versus 5/14 [36%]; RR=2.3;
95% C.I. = 1.1-4.9, P=.04). When controlled for household income, the association
between transition clinic attendance and less likelihood of regular appointment
attendance no longer approached statistically significance (Supplemental Table 4.5).
DISCUSSION
To our knowledge, this is the first report that compared pre-and post-transition
engagement in HIV care in a cohort of transitioned PHIV young adults. Both indicators -
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frequency of kept appointments and visit constancy- showed that engagement
deteriorated post-transition. Participants saw their HIV provider significantly less
frequently and less regularly in the first year post-transition compared to the last year in
pediatric care. Of particular concern was the increase in the proportion of study
participants, from 1 out of 30 (3%) in pediatric care to 9 out of 26 (35%) one year posttransition, who dropped out of care altogether or only had seen an adult provider in one
quarter. We did not observe any significant improvements in the second year posttransition, which might have suggested that patients needed time to adjust but eventually
would learn how to successfully navigate adult HIV care. The first year post-transition
seemed crucial to establish care-engagement behavior for the transitioned PHIV young
adults in our study. Similarly, a recent health care transition study of patients with
behavioral-and perinatally- acquired HIV suggested that retention in adult HIV care in
the first year post-transition may be a reliable marker of durable transition success.16
Retention studies among diverse US populations of HIV-infected adults also have
documented high attrition rates in the first year of enrollment in adult HIV care.27
Participants who were African-American or Haitian, or who lived in extreme poverty,
were less likely to be frequently engaged in adult HIV care in the first year post-transition
compared to Hispanic participants and those with higher incomes, consistent with
findings of other US studies.20,28,29
This study did not provide evidence for the effectiveness of the pediatric clinic’s
transition program to ensure a continuous transition. There is some evidence that
interventions for other chronically ill youth (primarily youth with diabetes), including
attendance at a transition clinic, meeting adult providers pre-transition and educational
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activities, increased appointment attendance and satisfaction.30 In our study,
economically vulnerable participants were significantly more likely to attend the
transition clinic. Identification of patients in highest need for enhanced transition support
could be a well-founded policy decision when resources are limited, especially when a
comprehensive program available to all is implemented on a systemic level. However,
both exposure to the comprehensive program and transition clinic attendance were not
associated with greater likelihood of consistent appointment attendance, one year posttransition.
Lack of transition program success may be partially explained by a “type III
error”: failing to detect program effectiveness because of problems in program design and
implementation.31 Participant satisfaction among transition clinic attendants was
relatively low, and over one-third only had visited the pre-or post-transition clinic. A
“dose-response” relationship may have been operating; the transition clinic may have
been of more help if attended more frequently. The data, however, suggest that transition
clinic attendance was not only unassociated with significant improvement in engagement
in care, but was actually associated with somewhat lower engagement in adult care. It,
therefore, appears that lack of program success was related to failure to address important
determinants of care-engagement behavior on different influential levels.32 Engagement
in adult HIV medical care results from the complex interplay of factors at individual,
social, community (including healthcare system) and policy levels.27 A mixed-methods
study of transition experiences of the same study participants concluded that experiences
in adult HIV care were characterized by the often times unmet need for patient-centered
care, with convenient, accessible services and a personal, caring relationship with adult
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providers.33 Study findings suggested that transition programs should include systemlevel interventions to improve access and delivery of adult services to better facilitate
transitioned patients, and recommended the use of a multi-level theory (socio-ecological
theory) and a systematic planning model to inform program development,
implementation, and evaluation.32
Study participants were more frequently and regularly engaged in pediatric than
adult HIV care, which seems to support the effectiveness of the pediatric clinic’s
comprehensive care services to retain patients in care. The comprehensive pediatric HIV
care model was developed to address the challenges of meeting the complex medical and
psychosocial needs of HIV-infected patients.34 Possibly, the comprehensive coordinated
primary care and psychosocial pediatric clinic services, the long-standing relationship
with pediatric providers, and clinic operations, including easy access, may have
compensated for some of the effects of social marginalization, poverty and HIVinfection.35-37 As PHIV young adults have complex medical and social needs, co-located
and integrated adult medical and social adult services more similar to the pediatric model
may be needed to prevent barriers or gaps in service delivery.38
Our findings are preliminary; limitations include the small sample size and
reduced power to detect statistically significant differences. Because this study was
conducted at a single-site among PHIV young adults, findings might not be applicable to
other settings and to behaviorally HIV-infected young adults. Our (mediator) outcome
measurement was restricted to engagement in HIV care, which is a pre-requisite for HIV
care, but may not be always translate to desirable health outcomes, specifically viral
suppression. Finally, program evaluation was planned and conducted about five years
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after the comprehensive transition program was implemented. Measurable objectives
were not established during planning, and opportunities to systematically monitor
program implementation were missed.
Despite these limitations, our study assessed key indicators at one- and two-years
post-transition, showing that engagement in care declined post-transition. Poor retention
and sub-optimal engagement in adult HIV care is a correctable cause of poor posttransition health outcomes and disparities. Sufficiently funded, sustained, and wellplanned strategies are needed to prepare PHIV adolescents and young adults for transition
and keep them engaged in care post-transition. Care-engagement behavior seemed to be
established in the first year post-transition, suggesting that this is a critical year for
establishing engagement patterns. This study suggests that differences in health care
delivery systems in pediatric versus adult HIV services impacts post-transition care,
indicating the need for much less fragmented, comprehensive adult care. Given the high
risk associated with poor post-transition outcomes, it is essential that promising, wellplanned models be developed, fully implemented, and systematically evaluated to try to
approximate in adult HIV care the comprehensive approach seen in pediatric care.
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Table 4.1. Study population: Sociodemographic and clinical characteristics
at time of transition to adult HIV care (N=31)
Characteristic

N (%)

Male gender

15 (48)

Race/Ethnicity
African American
Haitian
Hispanic

14 (45)
12 (39)
5 (16)

HIV-1 acquisition
Mother-to-child
Blood products
Sexual (abuse)
Married/in relationship

29 (94)
1 (3)
1 (3)
14 (45)

Completed high school/General Education Development test (GED)

27 (87)

Employed (full or part-time)

20 (65)

Household income
Equal or below Federal Poverty Level (FPL)
101-200% of FPL
201-300% of FPL
301-400% of FPL
Housing
Unstable, moved around
With (extended) family
Own or shared
Health Insurance
Medicaid
Ryan White
Medicare
Private
No insurance
CD4 T-cell count (cells/mm³)
< 200
200-499
≥ 500

15 (48)
9 (29)
5 (16)
2 (7)
1 (3)
14 (45)
16 (52)
20 (65)
7 (23)
1 (3)
2 (7)
1 (3)
12 (39)
8 (26)
11 (36)

Viral load (copies per ml)
<40
40-1000
≥ 1000

1 (3)
14 (45)
16 (52)

Age (years) at transition
Mean (SD)
Median
Mode
Transitioned after 1/1/08 (exposed to comprehensive transition
program)
Attended transition clinic
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23 (SD 1.7)
24 (18–26)
24
22 (71)
16 (52)

Table 4.2. Number of kept HIV appointments:
pre-transition, one- and two years post-transition
Period

N

Median Number
of Scheduled
Appointments Kept
(Interquartile Range)

Median
Difference
(Interquartile
Range)

Pre-transition (Pediatrics)
One Year Post-Transition
One Year Post-Transition
Two Years Post-Transition

251

5.0 (4.0- 6.0)
2.0 (1.0-10.0)
2.0 (1.0-4.0)
3.0 (1.0-4.0)

3.0
(0-4.0)
1.0
(-1.0-1.0)

202

P3

.002
.78

1

Thirty medical records were obtained from pediatric and 26 from adult clinics with information on visits
during the first post-transition year; records from 25 patients were obtained for both pediatric and adult
clinics.
2
Of the 25 adult clinic medical records with information from the first post-transition year, three belonged
to patients who transferred less than two years post-transition, and one patient died. Matched records were
available for 20 participants.
3
From Kruskal Wallis test for two groups

Table 4.3. Visit constancy (at least one quarterly kept appointment):
pre-transition, one- and two years post-transition
Number of
quarters in which
participant kept
at least one
appointment

Last year in
First
Pediatric
year
clinic
postn= 30
transition
n= 26

0 or 1 quarter
2 quarters
3 or 4 quarters
Total

1 (3)
5 (17)
24 (80)
100%

9 (35)
9 (35)
8 (30)
100%

p-value*

.006
.21
<.001

Second year
post-transition
n= 21

p-value †

8 (38)
5 (24)
8 (38)
100%

>.99
.63
.83

*Fisher exact two-tailed p-value, comparing last year in pediatrics to first year post-transition
†
Fisher exact two-tailed p-value, comparing first year post-transition to second year post-transition
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Table 4.4. Factors associated with regular engagement in adult HIV care,
1st year post-transition (n=26)¹
Characteristic at time of transition

n

Regular: ≥1 kept
appointment in 3
or 4 quarters n (%)

Male
yes
no

14
12

2 (14)
6 (50)

P-value²

.12

Non-Hispanic black
.04
yes
21
4 (19)
no
5
4 (80)
Married/in relationship
.31
yes
14
6 (43)
no
12
2 (17)
Completed high school/GED
>.99
yes
4
1 (25)
no
22
7 (32)
Employed
.62
yes
16
6 (38)
no
10
2 (20)
Household income below FPL
.06
yes
12
1 (8)
no
14
7 (50)
Lived with extended family
.70
yes
10
4 (40)
no
16
4 (25)
Medicaid insured
.38
yes
18
7 (39)
no
8
1 (13)
CD4 T-cell count <200 (cells/mm³)
.83
yes
9
2 (22)
no
17
6 (35)
Viral load
.12
≥ 1000 copies/ml
14
2 (14)
< 1000 copies/ml
12
6 (50)
Transitioned after 1/1/2008
>.99
yes
21
7 (33)
No
5
1 (20)
Attended transition clinic
.07
yes
15
2 (13)
no
11
6 (55)
¹ Of participants, we were able to locate 26 medical records one-year post-transition
² Fishers exact two tailed test (P= .05)
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Supplemental Table 4.5. Association of transition clinic attendance with regular
engagement in care in 1st year post-transition, controlled for poverty.
Living in Poverty (household income ≤ Federal Poverty Level)
Characteristic at Time of
Transition
Attended transition clinic
Yes
No

n

Frequent: ≥1 kept
appointment in 3 or 4
quarters n (%)

P-value1

10
2

1 (10)
0

>.99

Not living in Poverty (household income > Federal Poverty Level)
Characteristic at Time of
Transition
Attended transition clinic
Yes
No
Crude Prevalence Ratio
Adjusted Prevalence Ratio
1

.24
.38

n

Frequent: ≥1 kept
appointment in 3 or 4
quarters n (%)

5
9

1 (20)
6 (67)
95% C.I.)
(.06-.99)
(.07-2.1)

Fisher exact two tailed test (p=.05)
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P-value1

.27
P
.07
.39
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ABSTRACT
We conducted a mixed-methods study of perinatally HIV-infected young adults 25-34
years of age, who had transitioned from a pediatric clinic in Florida to adult settings.
Participants completed a computer-assisted survey about pre- and post-transition
experiences, satisfaction with transition program activities, demographics, and health
status. Information was supplemented with debriefing notes and medical record
abstraction. Data of 27 participants were analyzed using quantitative and qualitative
(thematic analysis) methods. While most of 27 study participants had received transition
services, 16 (59%) had trouble “doing well” in adult HIV care, nine (33%) had not seen
an HIV provider in the past six months, eight (30%) felt they were currently in poor
health, and 13 (48%) reported numerous unmet service needs in the past year. Transition
was experienced as a loss of emotional and practical support. Needs for convenient,
accessible adult HIV services and a personal, caring, relationships with adult providers
characterized post-transition experiences. Programs should transcend individual-level
interventions to prepare patients for transition, and include interpersonal (expand social
networks and mutual support) and system-level interventions (improve access to and
delivery of quality adult services) to facilitate transitioned patients.
Key words: health care transition, HIV, perinatally HIV-infected, transition programs
INTRODUCTION
Combination antiretroviral therapies transformed HIV infection from a
progressive, fatal disease to a manageable chronic condition.1 As the prognosis for HIV
infection greatly improved, most perinatally HIV-infected (PHIV) children who were not
expected to survive, are now adolescents or young adults.2 These long-term survivors

84

continue to be pioneers as they “age out” of pediatric or adolescent services and transition
to adult HIV-care settings.
A smooth transition between these fundamentally different systems of care
delivery is critical to achieving continued beneficial health outcomes, and purposeful
transition is considered to be a key component in continuing care.3 However, as is the
case with other chronic diseases, the development of theory-based transition programs
has not kept up with medical advances which have increased survival.4 The growing
body of transition literature for youth with chronic diseases has only just begun to
describe youth with HIV-infection.5 Despite strong agreement for the importance of a
purposeful, planned transition, limited data and little consensus exists as to which
transition services are needed and which strategies are most effective.6,7
Successful transition programs should be based on the young adult’s needs.4
Transition expectations and concerns of HIV-infected adolescents and young adults, their
caregivers, and providers have been the subject of several prospective qualitative
studies.8-10 Although these studies provide critical insights, a full understanding of the
issues and program implications must include the experiences of transitioned young
adults, as patients who still receive pediatric care may have a limited understanding of
upcoming challenges and expectations.4
Earlier, Wiener and colleagues11 reported on the experiences of youth with HIV
infection, most perinatally acquired, who transitioned from a large pediatric treatment
and research facility to adult HIV care in 23 different states and the District of Columbia.
This first study to report transition experiences and outcomes of PHIV young adults
elucidated concerns about the complexity of transition and potentially adverse health
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consequences of unsuccessful transition and interrupted HIV care, and reiterated the need
for adequate transition preparation. Because transition experiences and outcomes are
impacted by the health system and social context,12 we conducted a study of PHIV young
adults who transitioned from a pediatric HIV clinic and then, for the most part, continued
to obtain adult care in the same community. This study is a part of a larger research
project to assess post-transition mortality and engagement in adult HIV care in PHIV
young adults, and was conducted to assist in the interpretation of the quantitative findings
of these studies and to formulate program recommendations based on transitioned
participants experiences and needs.13 Our purpose was to describe exposure to and
satisfaction with the transition program, pre- and post-transition experiences, and
program recommendations in order to contribute to the development of effective, theorybased transition programs.
Context
This study was conducted in Florida, a southern US state with a very high
HIV/AIDS burden.14 Access to adult HIV care and services may pose difficulties as many
of our patients are covered under public health insurance programs (e.g. Medicaid) which
exposes them to gaps in insurance coverage.15 Patients are eligible for Medicaid
insurance until age 18, after which they may no longer qualify or may experience lapses
in coverage. Due to the Florida gubernatorial decision not to implement Medicaid
expansion, many low-income adults continue to have limited options for health coverage,
even after the implementation of the 2010 Affordable Care Act.16 Medicaid enrollment
and reimbursement in Florida is lower than the national average17 and falls short in
supporting comprehensive HIV care.18 Ryan White programs for uninsured or
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underinsured patients are inadequately funded to address the needs of the increasing
number of patients with HIV-infection who have complex medical and social needs.19
Consequently, the safety net of clinics and hospitals that serves the underinsured
population in Florida has been stretched in recent years.
All study participants had transitioned from a university-based pediatric HIV
clinic in Miami-Dade County, Florida; a county with the highest poverty rates in Florida
and with the highest HIV prevalence in the US.14,20 The pediatric clinic provides multidisciplinary, family-centered healthcare services to low-income and underserved
children, adolescents and young adults up to age 24 who acquired HIV early in life,
nearly all through vertical transmission. Comprehensive transition services were funded
and implemented in 2008. The transition programs aims to prepare and support patients
to independently navigate adult HIV services. Available services include program
components to: (1) prepare patients for independent living (including: educational and
psycho-social support, assistance to access housing and employment services, financial
assistance and medical insurance); (2) address the lack of continuity between pediatric
and adult HIV care (including: discussion of a transition plan, provision of linkage to
adult services, and a transition clinic to temporarily bridge pediatric and adult care), and
(3) increase patients’ self-management skills (including “life skills” training, support
groups, and one year post-transition follow-up by a transition social worker to teach
patients to solve problems encountered in adult HIV care). In the “transition clinic”21,22
patients could be seen by an adult provider in the pediatric clinic one year pre-transition.
In the first year post-transition, transitioned patients could schedule appointments with
the now familiar adult provider at the academic center’s adult HIV clinic, who allots
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more than the traditional 15-minutes for a routine medical visit. In the second year posttransition, no transition services were provided.
In a small study previously conducted at the pediatric clinic, patients and their
families expressed concerns about transitioning to the nearby adult immunology clinic,
because of its size, higher caseloads of adult physicians, and fewer available services.8
The university-based adult HIV clinic is located at the county’s public hospital through a
contract with the medical school. The clinic serves approximately 2,800 HIV-infected
patients, and funding for supportive or ancillary services is limited. Consequently, young
adults who transitioned may not receive the education and support they were accustomed
to in the pediatric clinic, including: follow-up in case of missed appointments; counseling
and home delivery services to support medication adherence; mental health services;
assistance with housing, transportation and completion of insurance paper work, and
other supportive services.
METHODS
Participants and Recruitment
Permission for this study was granted by the Human Subjects Committee of the
Institutional Review Board of appropriate institutions. Former patients were eligible for
participation if they had transitioned from the pediatric HIV clinic to adult care settings
between January 2003 and September 2012. Exclusion criteria were: (1) substantial
cognitive disability, as formerly established by staff psychologists at the pediatric clinic;
(2) incarceration, or (3) relocation.
Because experiences of patients who successfully transitioned may differ from
those who did not,5 we used several recruitment methods to maximize enrollment.
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Eligible patients were contacted by the pediatric program coordinator to introduce the
study. If up-to-date contact information was unavailable, we asked study participants to
inform their peers about the study. If interested, the study lead author, who did not have
any prior involvement with potential study participants, followed up to provide additional
study information and set up an appointment to review and obtain informed consent and
participants’ permission to abstract de-identified information from medical and social
records. Study recruitment began in September 2013 and was completed in February
2014. Study participants received $20 in cash and reimbursement for travel and parking
costs, and were offered support from pediatric staff to access adult medical or social
services, if needed and desired.
Study Design and Data Collection
This study used both quantitative and qualitative research methods to capitalize
on the strengths of a mixed methods approach.23 Study participants completed a
computer-assisted survey (Qualtrics), with open-ended and close-ended questions,
supplemented with demographic and clinical information, obtained from patient’s
medical records using a standardized abstraction form. The survey was conducted on-site
at the pediatric clinic.
Demographic information, including age, gender, race/ethnicity, educational level,
household income below or above poverty level [$24,250 for a four-person household in
2015],24 and transition date were abstracted from participant’s pediatric records. To
assess current circumstances, we asked participants to answer questions about housing,
family, and (any) employment, as well as gaps in medical insurance in the past 12
months. A measure of food insecurity, “In the past year, were you ever worried whether
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food would run out before you got money to buy more?” was used as a proxy measure of
current poverty.25 Data to assess engagement in adult HIV care were abstracted from the
adult medical record. Based on current HIV/AIDS performance measures, the expectation
for medical HIV care was at least one kept medical visit in the past 6 months.26
Questions to describe transition experiences and recommendations for future
programs were based on a semi-structured telephone transition questionnaire, developed
by Wiener and colleagues.11 Because this study used a computer-assisted survey to
collect study data, we could ask additional, detailed, questions about transition
preparation, experiences in adult HIV care, and unmet service needs. We asked both
quantitative (Likert scale) and qualitative questions (e.g. “could you please explain why”)
to examine how well participants felt prepared for transition, and to assess exposure to
and satisfaction with the pediatrics clinics transition program activities. This included
discussion of their transition plan, attendance at support groups and transition clinic, and
personal and clinical support received. We also asked participants to rate and explain how
easy or difficult it was for them “to doing well” in adult HIV care. Additionally, we
assessed usage and unmet needs of supportive and additional medical services in the past
12 months, including use of a Ryan White case manager, help with emotional and
financial problems, housing, employment or education, child care services, as well as
usage and needs for specialty services, including gynecology, dental and nutrition.
Debriefing after survey completion was offered to allow participants to further elaborate
on their answers. Participant quotes were written down verbatim and debriefing notes
were recorded in writing immediately after debriefing.
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Analysis
Quantitative analysis, conducted with SPSS 21, included univariate analysis to
present descriptive information, followed by bivariate analyses. Covariates were
dichotomized for inferential statistical analysis. Fisher’s exact two-tail test (alpha< 0.10)
was used to determine whether differences in categorical variables with few observations
were statistically significant.
Qualitative information was systematically analyzed using the thematic analysis
method; an iterative process followed to remain true to participant’s description while
developing more abstract concepts in various stages of data analysis.27 Analysis was
conducted manually, and included the following steps: familiarization with data and
repeatedly reading texts, generating of initial codes, grouping of codes by various themes,
and refinement and consideration of the meaning within and across themes. Initial coding
was conducted by two researchers; in the final, exploratory phase, the analysis was
discussed with a third researcher to explore associations between core concepts and
themes, established literature, and theoretical perspectives related to transition
experiences of PHIV young adults.
Data Validation Strategies
Pre-testing, informal respondent validation, and peer review were used to ensure
adequacy and plausibility of the qualitative data. First, the survey instrument was
pretested with six clinic patients who would transition within one year. Based on their
recommendations, we revised questions which were unclear and added open-ended
questions to provide participants more opportunities to “tell their stories.” Second, after
survey completion, we asked participants if any questions were unclear and if they
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wished to clarify or elaborate, in order to enable them to correct potential
misunderstandings and add information they believed was important. Hand- recorded
verbatim quotes were validated with the participant. Third, to minimize pre-conceived
notions and potentially expand alternative explanations, we conducted multiple coding by
two different researchers. Both researchers had HIV-related research experience, but not
with PHIV adolescents or young adults. To further minimize researcher bias, a third
researcher, who had former clinical and research experience with PHIV adolescents and
young adults but had not been involved in the study design or data collection, reviewed
the analytic framework and data interpretation.
RESULTS
Between January 2003 and September 2012, 51 patients transferred from the
pediatric clinic to an adult medical HIV-care setting. Of these, nine patients (18%) had
died when data collection was completed, and nine more (18%) were ineligible for study
participation because of cognitive impairments (n=3); incarceration (n=1), or relocation
(n=5). Of the 33 eligible patients, one patient was lost to follow-up; five patients refused
or did not return phone calls, and 27 (82%) agreed to participate. Reasons for nonparticipation were not ascertained.
Quantitative data
At time of study enrollment, participants were between 25-34 years of age
(Mean=27 years); most had transitioned from the pediatric clinic to adult HIV care at 24
years of age (Table 5.1). All participants were members of a racial or ethnic minority
group, primarily African-American, most had completed high school or GED
requirements, were currently housed, and had some type of employment. Fourteen out of
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27 (52%) currently lived independently from their families or caregivers, were in a steady
relationship, and had dependent children. At the time of study participation, 12 (44%) had
experienced food insecurity in the past 12 months. About one-third of participants
recounted a gap in their medical insurance coverage, had not kept an appointment with
their adult HIV provider in the past 6 months, and felt they currently were in poor health.
Participants who had not seen an HIV provider in the last 6 months, were more likely to
assess their health as “poor” (5/8 [63%] versus 4/19 [21%] in “good” or “excellent”
health; P= .07), and to report gaps in health insurance coverage in the past 12 months (5/8
[63%] versus 4/18 [22%] no gaps in health insurance coverage; P=.08).
Participants’ transition experiences were mixed. Fifteen out of 27 (56%)
participants remembered that transition was “easy” or “very easy,” although 11 (41%)
reported that transition had been more difficult than expected. Most participants (23 out
of 27) recalled that someone had discussed a transition plan with them. Participants
reported that medical providers and pediatric clinic staff were most helpful in preparing
them for transition, compared to family members and peers (Table 5.2). Appreciation of
transition clinic attendance was rated relatively low compared to participation in support
groups: 8/17 [47 %] versus 6/8 [75%] of participants rated the intervention as “helpful,”
respectively.
Overall, 6 out of 10 participants reported it had been difficult for them to do well
in adult HIV care, and many had problems post-transition (Table 5.3). Almost half of
participants (14 out of 27) experienced a multitude (three to seven) of unmet needs for
supportive and ancillary medical services in the past 12 months. Most frequently
mentioned unmet needs were: support with finances, employment and education, and
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dental and nutritional services. Participants who reported a multitude of unmet needs
were more likely to have not completed high school/GED requirements (3/3[100%] noncompletion versus 10/24 [42%] completion; P=.10), and to report a gap in health
insurance coverage in the past 12 months (6/8 [75%] versus 6/18 [33%] no gap in health
insurance; P=.09).
After transition, 19 participants had stayed in contact with the pediatric clinic. Of
the eight participants who did not, six thought they should have remained in contact.
Only two participants reported they had not needed any help from pediatric staff posttransition.
Qualitative data
We identified themes in the following major categories: (1) transition
experiences, (2) experiences in adult HIV care, and (3) recommendations for transition
programs.
1. Transition experiences
The overarching theme was “loss;” as represented in three sub-themes: (1) loss of
long-term, close relationships with pediatric staff; (2) loss of “quality” services, and (3)
loss of familiar, known, care. As previously noted, transition experiences were mixed.
However, none of the participants described benefits associated with transition to adult
HIV care.
Loss of close relationships with the pediatric team
When participants were asked to explain why transition was difficult or easy for
them, many referred to the long-term, close relationships they had with their pediatric
team, which transcended professional, patient-physician relationships. As one participant
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described, “You [are] practically raised here. They have become like family to you”
(Hispanic male, transitioned 8 years ago). Similarly, another participant replied : “I was
very comfortable in the pediatrics because the doctor basically raised me from when I
was a little girl and they was the only doctor I know that was there every step of the way”
(African-American female, transitioned 2 years ago). Several participants referred to
strong emotional bonds with pediatric staff. One participant wrote: “I was very attached
to everyone, like the other patients, the doctors, the social workers and everyone else who
was part of the team” (African-American female, transitioned 10 years ago), while
another simply stated “I love it there” (African-American male, transitioned 1 year ago).
Transition had been difficult not only because it was “difficult to let go of family”
(Hispanic male, transitioned 8 years ago), but also because it would be difficult “finding
people that care the way peds [pediatric clinic] treats you. I do not have any family
except for him [his son]. I found some type of family here” (African-American male,
transitioned 3 years ago). Another participant wrote: “Now I’m basically alone but I
guess I am getting older” (Haitian male, transitioned 1 year ago). The importance of
personal support was also expressed by a participant who felt transition was easy,
“Because of the support system I had with my family” (Hispanic female, transitioned 1
year ago).
Loss of “quality” services
In addition, participants referred to the loss of easy accessible services and
tangible support of the pediatric team to explain difficulties with transitioning. One
participant briefly stated: “Pediatrics provided the best service” (African-American
female, transitioned 3 years ago), while another remarked: “I was used to getting VIP
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treatment and everything was handed to me, but now things have changed a lot” (Haitian
male, transitioned 1 year ago). Differences in required autonomy between pediatric and
adult HIV care were also recognized by others. For example, one participant explained
difficulties with transition as follows: “They (Pediatric staff) are here for you. They help
us a lot more” (African American male, transitioned 1 year ago), while another
participant wrote: “Everything was much more simple and easier for me” (AfricanAmerican female, transitioned 10 years ago).
Loss of familiar care.
While a few participants reported that transition had been easy because they
already had met the adult HIV provider or were receiving adult (specialty) care services,
others reported that transition was difficult because they were unsure of what to expect.
For example, one participant wrote: “It was difficult to imagine what it would be like
somewhere else and how their services would be compared the one received since
pediatric care” (Hispanic female, transitioned 1 year ago). More specific concerns were
expressed by others. While one participant was worried about the adult clinic
environment “I was not ready for that world and how other people got the disease”
(Haitian female, transitioned 8 years ago), others recalled concerns regarding the quality
of the relationship with their adult provider. For example, one participant wrote: “Will
the doctor listen to me was a major concern as well” (African-American female,
transitioned 3 years ago). Another said: “I had to get used to someone which is very hard
to me because I have to trust someone with my information” (African-American female,
transitioned 4 years ago).
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In contrast, some participants may have engaged in avoidance coping and
reported they had not believed that adult HIV care would be different. As one participant
explained in the de-briefing: “They [pediatric staff] tell you that you will be on your own
but you do not really listen” (African-American male, transitioned 2 years ago).
Similarly, another participant said: “I did not take it too seriously. I really did not think it
would be so different. I figured it would be much easier than they told me. Until it hits
you… I was not coping too much. It’s like going from high school to college” (AfricanAmerican male, transitioned 3 years ago).
2. Experiences in adult HIV care
As noted previously, six out of 10 participants felt it was difficult for them to do
well in adult HIV care. Two primary themes became apparent: (1) access to adult HIV
care, and (2) the relationship with the adult HIV provider. In both, the perception of
“being cared for” seemed to be important.
Access to HIV care: Need for accessible and convenient services
All participants reported they had experienced problems accessing adult HIV
care. Most were “straightforward” access problems, including problems making
appointments, getting urgent care questions answered, and difficulties with obtaining and
keeping health insurance coverage. For example, participants reported they did not know
“How to follow up on future appointments,” (Hispanic male, transitioned 2 years ago);
or wrote: “I need help to remind me of when my appointment with the doctor is cause I
tend to forget” (Haitian male, transitioned 2 years ago). Two participants, both currently
not engaged in HIV care, described how inter-personal and system-related issues may be
related. One participant wrote: “Amazing doctor, took amazing care of me. Problem was
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to get into her office to see her. They did not pick up the phone” (Hispanic male,
transitioned 2 years ago). Another reported similar experiences: “She [adult physician]
is a nice lady, it’s not her. It’s the system. It was the waiting and the trouble of making an
appointment. Did not feel right over there” (African-American male, transitioned 2 years
ago).
Several participants reported that staff of the adult clinic had accommodated
them. For example, one participant said: “I did not know how to do it. Now they make
them [appointments] for me” (African-American female, transitioned 4 years ago).
Another participant wrote: “I can call him [physician] whenever, he calls me back, puts
me on the list when I need to see him. He is personal” (African-American female,
transitioned 10 years ago). The importance of easy access was also noted by participants
who described problems with urgent care or walk-in appointments. As one participant
worded it: “You leave a message with the nurse and when it is really urgent they call you
back. I like my doctor, but I do not like the system” (Hispanic female, transitioned 4
years ago). Another participant commented: “In the adult clinic you were just a number.
You cannot just show up”. After changing providers, he said: “You can just walk in and
speak to someone who is there” (African-American male, transitioned 4 years ago).
Finally, as noted previously, many participants had experienced difficulties with
health insurance. In particular, public insurance was perceived to be complicated to
navigate. For example, one participant wrote: “They [Medicaid insurance] made it very
difficult for me to enroll again” (African-American male, transitioned 4 years ago), while
another stated: “Ryan White is a nightmare over here. It’s much easier in Broward
[adjacent county], I tell everyone to move” (Haitian female, transitioned 3 years ago).
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Remarking on the advantages of private health insurance, another participant wrote: “It
wasn’t too bad for me because I had private health insurance through my job and was
able to choose a really good doctor. I have heard some of the experiences other people
had and they were not good experiences so I am glad I was able to avoid that” (Haitian
female, transitioned 3 years ago).
Physician-patient relationship: Need for a personal, caring relationship
Many participants described their perception of the relationship with a HIV
provider and indicated the importance of a personal and caring relationship. For example,
one participant stated, “Adult care is not personal” (African-American male, transitioned
1 year ago), while another wrote: “Most doctors I went to were very generic and cold.
They lacked the connection and care I received since birth” (African-American female,
transitioned 8 years ago). The strong feeling of “not being cared for” after transition was
frequently mentioned. For example, one participant concluded: “Now we are adults, they
do not care anymore” (African-American female, transitioned 3 years ago).
Several participants explained why they believed a personal and caring
relationship with the adult physician was important. One participant changed doctors a
couple of times, until she found, “Someone who takes the time for me. AIDS is not just a
disease, but it influences my whole life, everything. My doctor now understands that. He
takes a lot of time for me and really wants to know how I am doing. He is interested in
me” (Haitian female, transitioned 8 years ago). Others described how the physicianpatient relationship may impact how well patients take care of themselves. For example,
one participant wrote “They stop caring. I think that’s why so many die. If you do not
have the support of your family you get lost” (African-American male, transitioned 3
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years ago). Several participants concurred. For instance, one participant stated: “They do
not care for you in adult care. You just lose interest in that part of your life” (AfricanAmerican male, transitioned 3 years ago), while another said: “They just went through
the motions. If they care, you will take better care of yourself also” (African-American
female, transitioned 10 years ago).
3. Recommendations for transition programs
All participants offered recommendations for improving of the transition program.
The following subcategories were developed (1) “Make it real,” (2) Match patient with
HIV care that is responsive to their needs, and (3) Increase continuity between pediatric
and adult care.
As noted before, possibly with the exception of participants who had previous
experience in adult (specialty) care, many observed they were aware that adult HIV care
was “another world,” but had limited understanding of future expectations. Some
participants seemed to manage uncertainty with avoidance coping, which may have led
them to advise: “To listen and be focused on what they say. I did not want to believe it
until it’s in front of me” (African-American male, transitioned 2 years ago), while others
recommended “To make [patients] clear that things are going to change” (AfricanAmerican male, transitioned 3 years ago), and to “Keep reminding them” (Haitian
female, transitioned 8 years ago). Limited understanding of future expectations in adult
care settings may have led participants to recommend to: “Giving the patients the reality
of the outcome” (African-American female, transitioned 10 years ago), or “Get them
more prepared, like months ahead so they know exactly what’s going to happen when
they actually get there” (African-American female, transitioned 4 years ago).

100

Participants suggested that interventions include peer education or modeling or:
“Having someone who has gotten through transition and be somewhat of a guide to
others to let them know that it is possible to come out on the other side” (Hispanic
female, transitioned 1 year ago). Others recommended that staff “Walk you through
everything until one foot is inside the door” (Haitian male, transitioned 1 year ago).
Another recommendation was to match transitioning patients with accommodating
clinics, physicians and other providers. For example, as one participant recalled: “I
should have gone to another clinic.… I would have done better. If you do not show up at
[clinic name] they do not call you. At [clinic name] they call” (African-American male,
transitioned 2 years ago). Others advised to provide choices of adult providers to “Make
sure the patient is with the best doctor that suits their needs” (African-American female,
transitioned 10 years ago), or “Give a list of providers who can relate to young/working
adults or college students.” (African-American female, transitioned 8 years ago).
Participants suggested that more continuity between pediatric and adult care
would be beneficial. As stated by one participant: “It’s very different especially coming
from somewhere that does everything for you [and] all you have to do is show up”
(Haitian female, transitioned 8 years ago), while someone else wrote :”They [insurance]
send me papers but I never looked at them because they [Pediatric staff] were taking care
of it. Now I have trouble and do not know how to do it” (African-American female,
transitioned 2 years ago). Increasing self-management of pediatric patients was,
therefore, recommended. For example, one participant advised to: “Make sure they are
willing to take their meds because u have no one to push or encourage you to take your
medicine. It’s all up to u” (African-American male, transitioned 1 year ago). Meeting an

101

adult provider a couple of times before transition was suggested. As one participant
explained: “The patient will feel comfortable and build a relationship with them before
leaving” (Hispanic female, transitioned 4 years ago).
Continued support of the pediatric team and follow-up after transition to adult
HIV care was proposed. As one participant stated: “Once you are out there you know
how it is” (African-American male, transitioned 2 years ago). Recommendations
included: follow-up by a pediatric social worker “To show them how to do things on their
own” (African-American female, transitioned 10 years ago); support groups (AfricanAmerican male, transitioned 3 years ago), and “A few check- up calls throughout the
year to see how the patient is doing” (Haitian female, transitioned 3 years ago). Many
also recommended continued assistance with medical insurance and provision of access
to services post-transition.
DISCUSSION
Both quantitative and qualitative methods were used to describe the experiences
of 27 PHIV young adults between 25-34 years of age, who transitioned from a pediatric
clinic to adult HIV care in Miami-Dade County, Florida. HIV/AIDS disproportionally
impacts already vulnerable populations;28 all study participants were members of a racial
or ethnic minority group, primarily African-American, and most were low-income.
Participants had transitioned from a pediatric clinic with comprehensive HIV services to
adult HIV care settings with less or no ‘wrap around” services, in a community with a
high HIV/AIDS burden and limited resources. In the few available studies of transitioned
young adults, all participants were currently engaged in HIV care.5,11 In our study, nine
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out of 27 participants (33%) did not have an appointment with an HIV provider in the
past 6 months.
Transition experiences, including loss of longstanding relationships with the
pediatric team and loss of supportive services, were similar to those described in
transition studies of youth with chronic diseases, including youth with HIV.8,11,29,30 In
contrast, none of our participants described benefits of transitioning to adult HIV care,
such as increased control and autonomy, suggested by others.5,9 Most participants
recalled preparation for transition, had discussed a transition plan, and had received
support from the pediatric clinic team for the transition process. Nevertheless, 11 out of
27 (41%) participants reported that transition was more difficult than expected; findings
which were comparable with results reported previously.11 Transition preparation may
have been hampered by avoidance coping, which was found to be a widely used strategy
to cope with HIV infection in a study of HIV-infected adolescents.31 In addition,
participants without prior adult care experience recalled that they had a limited
understanding of future expectations in adult HIV care, as was observed in other studies
of PHIV adolescents.9,32
HIV-infected adolescents and young adults have been characterized as a ‘hidden
population,’ due to their experiences with and fears of HIV/AIDS stigma.33 De Santis and
colleagues31 described how social isolation starts at disclosure when PHIV adolescents
are told to keep their HIV diagnosis secret, and is further reinforced by community
stigma. Although concealment of HIV status may be appropriate in an unsupportive
environment, concealment also acts as barrier to social support, which includes emotional
(empathy, caring), instrumental (provision of services), informational (advice or
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suggestions), and appraisal (feedback for self-evaluation and affirmation) help through
social interactions.34 The extent and nature of social support has been associated with
health status and may influence the ability to remain in care.35,36 Explanatory mechanisms
include modeling and reinforcement of desired behaviors, buffering of stress, and
provision of access to resources.34 Previous studies of PHIV youth and health-care
providers also suggested that HIV/AIDS stigma impacted both treatment and care
transition, and reported disclosure concerns and anxieties about the adult clinic’s more
diverse patient population.5,7,10,11 Our study suggests that the impact of HIV/AIDS may
be more extensive. In particular, we were struck by feelings of loneliness and social
isolation. After participants transitioned to adult HIV care, they lost the extensive social
support of the pediatric team and their peers. As one participant expressed: “Now I am
an adult, I am basically alone.”
In a concurrent retrospective, longitudinal study, we observed that participants
were less frequent and less regular engaged in adult HIV care in the first post-transition
year, compared to the last year in pediatric care.13 No significant changes were observed
between the first and second post-transition year. Results of this study expand upon these
findings. Overall, 16 out of 27 (59%) participants reported it had been difficult for them
to do well in adult HIV care, and many had experienced problems post-transition,
including more difficulties taking meds as prescribed and more medical needs and
complications. These results may not be surprising, as several studies have documented
suboptimal clinical and retention outcomes among HIV-infected youth and young adults,
but they are concerning.37-39 Successful transition is particularly important for PHIV
young adults, as many may be in advanced stages of HIV-disease and have complex
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medical histories, which complicates treatment and limits therapy options.40 Patients
must keep frequent appointments and adhere to strict medication regimens, as poorly
managed HIV infection will have adverse consequences for both personal and public
health.41,42 Unmet needs for food, income or other essentials may have made it difficult
for participants to prioritize their health care.43 Although supportive services are available
in the community, many participants reported problems accessing these services posttransition, and 14 out of 27 (52%) participants experienced a multitude of unmet needs
for supportive and ancillary medical services in the past 12 months. Despite resource
allocation for supportive services for low-income people with HIV-infection, barriers that
prevent access and service utilization, including poor publicizing of available services,
and systemic problems such as confusing systems, long wait lists and financial barriers,
were documented among other HIV-infected patient populations.44
Clearly, medical advances in HIV treatment will have little benefit without an
understanding and improvement of systems responsible for attracting people to their
services and retaining them in care.45 In our study, many participants reported it was
difficult for them to do well in adult HIV care. In general, research indicates that positive
patient-care experiences are associated with greater adherence to recommended care,
better clinical-care quality outcomes, and less health care utilization.46 In summary, many
of our participants felt that the adult health care system fell short in meeting their needs.
Participants reported having problems to access adult HIV care and perceived their
relationship with an adult provider to be “impersonal.” Access problems included
problems making, changing and remembering appointments, getting urgent care
questions answered, and long wait times. Similarly, a study of patient experiences in
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England found straightforward initial access elements (including the ability to get
through on the telephone and problems to make appointments) to be most strongly related
with quality of care.47 In addition, previous studies have documented difficulties with
medical insurance as important transition barriers.5,7,10,11 Likewise, 11 out of 27 (41%)
study participants reported problems with medical insurance after transition, while eight
out of 27 (30%) reported a gap in medical coverage in the past 12 months. In our study,
we observed an association between poor engagement in adult HIV care and gaps in
medical insurance; other studies of HIV-infected adults reported an association between
gaps in medical coverage and viral rebound and clinically significant resistance.48
Financial barriers to regular HIV care are worrisome as they may impact both personal
and public health. Participants’ problems with obtaining and keeping health insurance
coverage post-transition warrant a further exploration of the accessibility of public
insurance in our community.
Different physician-patient relationships in adult care compared to pediatric care,
with providers being more impersonal and disease-focused, seems to be a common,
shared, experience among transitioned youth with chronic diseases, including HIVinfection.5,11,29 Although some participants were very complimentary about the ‘personal’
relationship with their physician, others experienced a mismatch between their own and
providers’ expectations. In essence, participants expressed the need to be treated as a
person and wanted their physician to care for them, while they felt their physician treated
their symptoms and took care of them. Patients’ needs for patient-centered care and an
affective, supportive relationship with their medical provider should be sufficient
justification to transform the patient-provider relationship. However, as also was
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suggested by our study participants, the quality of the patient-provider relationship has
been found to be associated with disease management and health outcomes.18
Traditionally, transition programming has been the responsibility of pediatric and
adolescent providers and little has been done by adult providers to ensure that the needs
of transitioned patients are being met.49 Because of concerns that the adult clinic would
require an autonomy level that pediatric patients may not possess, increasing selfmanagement skills to prepare young adults to independently navigate the health system
became an important goal of transition programs for youth with chronic diseases.4 Or, as
stated in the position paper “Transitioning HIV-infected youth into adult health care” of
the Academy of Pediatrics (2013):
Seamless and successful transition from pediatric to adult-oriented care is
dependent on these youth acquiring skills to allow them to be responsible for their
management of their own health care. A well-planned transition enables youth to
optimize their ability to assume adult roles and responsibilities.3(p193)
Although enabling and empowering youth with HIV infection to self-manage
their HIV disease is important for daily disease management, the emphasis on individual
behavior also leads to a narrow-focus on changing the behavior of individuals, with
limited attention for other factors that may inhibit or facilitate required behaviors.
Consistent with the socio- ecological theory,50 participants experienced multi-level
barriers in adult HIV care, including lack of social support (inter-personal), problems to
access adult HIV care and supportive services, and impersonal relationships with adult
providers. These barriers are influenced by community and macro-level (policy)
influences, including HIV/AIDS stigma and the availability and allocation of resources
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for HIV care for the poor. Consequently, multiple retention strategies appear to be
necessary to effectively address barriers to adult HIV care.51
Participant recommendations for improving transition programs reiterated
suggestions in previous studies and position papers, including but not limited to: timely
preparations, meeting adult providers pre-transition, and post-transition follow-up to
provide assistance with medical insurance and access to services.3,52 Because transition
from pediatric to adult care is guided by individual transition readiness and preparation,
transition models and strategies focus on preparations at the individual-level. Given the
social isolation of many PHIV young adults and the importance of social support for
disease management, we suggest to transition patients in cohorts, instead of individually,
and to develop (on site or and/or on-line) group-level interventions. Recently, a hospital
in northern Thailand reported their experiences with preparing and transitioning patients
in groups, which facilitated positive peer interactions and mutual support.53 In addition,
with limited available resources, cost-effective group-level interventions allow clinic staff
to address collective needs and establish networks for mutual assistance and on-going
support. We recommend that these groups be continued post-transition, as patients may
encounter problems in adult HIV care they did not anticipate and were not prepared for.
These group-level interventions should be co-managed by members of both pediatric and
adult teams. Planning models should be used to guide program development,
implementation, and evaluation to contribute to the development of evidence-based
transition programs.54
There are limitations to the present study. First, this study was conducted among
patients of a single pediatric clinic. Therefore, experiences of these patients may not be
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reflective of those young adults with PHIV elsewhere. To allow readers to determine if
study results have relevance for other clinical settings and patient populations, we
provided detailed descriptions of our study population, study context, and findings.23 In
addition, recall bias is possible because participants were asked to reflect on experiences
that have occurred in the past. Finally, qualitative studies are inherently concept and
hypothesis generating and not confirming.
Despite these limitations, this mixed-methods study of transitioned young adults
with PHIV has important implications. First, future programs to prepare youth for
transitioning should expand beyond programs to increase individual transition
preparation to group-based interventions that build capacity of groups of PHIV young
adults to cope collectively with transition to allow for mutual learning, empowerment,
and on-going support. Ample resources should be made available for program planning,
implementation, and timely evaluation to contribute to the development of evidencebased transition programs. Second, a successful transition will not only depend on
effective transition preparation, but also on the capacity of the adult health system to
retain patients in optimal care. Our results highlight the need for continuing improvement
in the delivery of HIV care and supportive services in south Florida, which will require
dedicated resources and attention. In essence, our participants expressed the need for
patient-centered care, which addresses patients’ needs for a personal relationship with
their physician and convenient and accessible services.55 Because of the social, economic,
and medical vulnerability of many PHIV young adults, we recommend to explore
strategies to increase the continuity between pediatric and adult HIV care, including
models to offer pediatric and adult HIV care at the same clinic site with shared
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comprehensive services, or the creation of a network of adult HIV providers and social
service organizations that are willing and able to “go that extra mile” to meet the needs of
transitioned patients. Finally, resources should be mobilized to counter HIV/AIDS
stigma, which continues to adversely affect the lives of people with HIV-infection.56
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Table 5.1. Characteristics of study participants (N=27)
Characteristics

N (%)

Race/ethnicity
African American/Haitian
Hispanic
Gender
Female
Male

22 (87)
5 (13)
14 (52)
13 (48)

HIV transmission
Vertical
Transfusion
Sexual (abuse/child)

25 (93)
1 (3)
1 (3)

Age in years at transition
Mean (SD)
Median (range)
Mode
Years in adult HIV care
Mean (SD)
Median (range)
Mode
Foreign Born
Yes
No
Biological mother deceased (at time of transition)
Yes
No
Dependent children
Yes
No
Completed GED/high school
Yes
No
Currently employment (full or part-time)
Yes
No
Income at or below federal poverty line at transition
Yes
No
Food insecurity past 12 months
Yes
No
Current relationship status
Married/in relationship
Single
Current living arrangements
Moving around/unstable
With (extended) family
Own/shared
Health insurance gap past 12 months *
Yes
No
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23 (1.6)
24 (18-25)
24
4 (2.8)
3 (1-10)
1
5 (18.5)
22 (81.5)
24 (89)
3 (11)
14 (52)
13 (48)
24 (89)
3 (11)
17 (63)
10 (37)
11 (41)
16 (59)
12 (44)
15 (56)
14 (52)
13 (48)
3 (11)
10 (37)
14 (52)
8 (30)
18 (67)

Health status (self-report)
Excellent/good
Fair/poor

19 (70)
8 (30)

Engagement in HIV care past 6 months
At least one visit
No visit

18 (67)
9 (33)

*Missing one respondent reply

Table 5.2. Who/what was helpful to prepare you for transition?
Felt supported by:

n (%)

Medical providers
Very/quite helpful
Somewhat/not helpful

23 (85)
4 (15)

Staff of the pediatric clinic
Very/quite helpful
Unsure
Somewhat/not helpful

11 (78)
3 (11)
3 (11)

Parents/guardians or other family members
Very/quite helpful
No reply
Peers from the pediatric clinic
Very/quite helpful
Unsure
Somewhat/not helpful

12 (44)
15 (56)
10 (37)
4 (15)
13 (48)

Transition clinic attendance (n= 17)
Very/quite helpful
Unsure
Somewhat/not helpful
Attendance of support groups (n= 8)
Very/quite helpful
Unsure
Somewhat/not helpful

8 (47)
3 (18)
6 (35)
6 (75)
1 (13)
1 (13)
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Table 5.3. Experienced problems after transition to adult HIV care
Problems post-transition

n (%)

It has been difficult for me to do well in adult HIV care
Yes
No
More difficulties to take meds as prescribed
Yes
Maybe
No
More medical needs or complications
Yes
Maybe
No
Problems with medical insurance
Yes
Maybe
No
Difficulties finding supportive services
Yes
Maybe
No
Problems finding HIV provider
Yes
Maybe
No
Unmet service needs in the past 12 months
0 - 2 needs
3 - 7 needs
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16 (59)
11 (41)
12 (44)
1 (4)
14 (52)
11 (41)
1 (4)
15 (56)
11 (41)
2 (7)
14 (48)
10 (37)
3 (11)
14 (52)
8 (30)
1 (4)
18 (67)
14 (52)
13 (48)

CHAPTER VI
CONCLUSIONS AND PROGRAM RECOMMENDATIONS
Transition from pediatric to adult HIV care may lead to poor health outcomes, but
few studies have examined the effects of transition and programs to improve posttransition outcomes. The purpose of the three studies comprising this dissertation was to
assess health outcomes and experiences of PHIV young adults who had transitioned from
a pediatric out-patient clinic in Miami-Dade County, Florida, to adult care settings
between January 2003 and September 2012. The first two studies examined posttransition health outcomes, including mortality and engagement in adult HIV care. While
these studies provided valuable follow-up information on important health outcomes,
they contributed little to the understanding of the experiences from the perspectives of
transitioned young adults. The third study explored their experiences and
recommendations for improvement of the transition program.
The first study examined post-transition mortality and associated clinical and
socio-demographic factors. Transition was associated with high mortality (18%),
especially in patients who were severely immunosuppressed, unemployed or less
educated at time of transition. Most patients (56%) had died in the first year posttransition. Because of the poor health status of deceased patient at transition, it is unclear
whether transition had negatively impacted the disease course. Transition clinic
participation was preferentially recommended to patients living in extreme poverty or
with severe immunosuppression; when controlled for these factors, mortality risk was
identical among transition clinic attenders and non-attenders, suggesting that this
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intervention did not impact mortality. We recommended that comprehensive programs
focus on improvements in clinical care and include academic and employment services.
Continuous HIV care is essential, as even short lapses in care and treatment may
have significant consequences for viral suppression, drug resistance, and HIV
transmission. The second study examined a pre-requisite for HIV treatment - regular
engagement in HIV care - and assessed if the transition program had achieved its goal of
continuous care. Multiple measurements, including the number of kept appointments and
visit constancy, showed that engagement in HIV care significantly decreased posttransition, especially among African American or Haitian and low-income participants.
Compared to the last year in pediatric care, study participants were less frequently and
less regularly engaged in adult HIV care in the first year post-transition. Particularly
concerning was the significant increase in poorly engaged participants from 3% in
pediatric to 35% in adult HIV care. No significant changes were observed between the
first and second year post-transition, suggesting that the first year post-transition was
crucial to establishing a behavioral pattern. The finding that study participants kept more
(regular) HIV appointments in pediatric than adult care seemed to support the
effectiveness of pediatric comprehensive services to retain their patients in care.
Possibly, the comprehensive coordinated primary care and psychosocial pediatric clinic
services, the long-standing relationship with pediatric providers, and clinic operations,
including easy access, compensated for some of the effects of HIV-infection, social
marginalization, and poverty experienced by PHIV young adults.
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Engagement in adult HIV care was identical among participants and
nonparticipants in the transition program. Lack of transition program success may be
partially explained by a “type III error”, that is a failure to detect program effectiveness
because of problems in program design and implementation. As the transition program
focused on influencing personal determinants and preparing patients for requirements of
adult HIV care, environmental determinants that may inhibit engagement in adult care
were inadequately addressed.
Despite strong agreement of the importance of a purposeful, planned transition,
limited data and little consensus exists as to which transition services are needed and
which intervention strategies are most effective. Successful transition programs should be
based on young adult’s experiences and needs, which were explored in the third study.
While most participants had received a range of transition services in pediatric care,
many said it was difficult for them do well in adult HIV care and reported a multitude of
unmet service needs in the past 12 months. Participants had experienced transition as a
loss of (emotional and instrumental) support and familiar care. Exploratory analysis
suggested that social and system-related determinants shaped individual transition
experiences, including poverty (limited access to resources), HIV/AIDS stigma (limited
social support), and system differences between pediatric and adult care (lack of
continuity of care). Consistent with socio-ecological theory, participants experienced
multi-level barriers post-transition, including social isolation because of HIV/AIDS
stigma, impersonal, “non-caring,” relationships with adult providers, and problems
accessing adult HIV care.
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Participants recommended continuation of assistance post-transition and
expressed a need for patient-centered adult HIV care, which is designed to address
patients’ need for a personal relationship with their physicians and considers their
experiences with access, including convenience and easy accessibility of services.
Because of the social isolation of many PHIV young adults and the importance of social
support for disease management, we proposed to transition patients in cohorts, instead of
individually, and develop group-level interventions to establish social networks and
facilitate mutual, ongoing support. Planning models should guide program development,
implementation, and evaluation to contribute to the development of evidence-based
transition programs.
Some limitations and strengths of this research are important to note. This study
was a single center study of a large pediatric clinic, which required fewer resources than a
multi-center study and allowed for more involvement of pediatric clinic staff and
collection of data potentially of relevance for the pediatric clinic’s program. However, a
small scale, single-center study also carries the risk of recruiting too few participants to
make meaningful comparisons and detect statistically significant differences. Limitations
of this study included the small sample size, non-eligibility and non-participation of 15 of
51 patients, and limited generalizability of study results. The first two studies were based
on retrospective analyses of pre-existing data available in medical and social patient
records, which came with the risk of missing information on potentially relevant factors
not available in established datasets (including data on substance use and mental health),
and with problems to assess temporal relationships. Participants transition experiences
and recommendations, as described in the third study, may have been influenced by recall
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bias. Their experiences are context dependent and may not be reflective of experiences of
PHIV young adults elsewhere. An important study question was if the transition program
affected transition outcomes. An experimental study design, in which study participants
are randomized to intervention and control interventions, would have been superior to the
observational design of this study. As little information was available regarding which
specific program interventions were delivered to which participants, we were unable to
assess and compare the differential effects of various components of the comprehensive
transition program, with exception of the transition clinic intervention.
These studies have implications for the development of transition programs and
for future research. First, although enabling and empowering youth with HIV infection to
self-manage their disease is important for daily disease management, this approach may
lead to a narrow focus on psychological attributes and individual behaviors, while
system-level and structural barriers that may inhibit or facilitate required behaviors are
ignored or inadequately addressed. The notion that adequate transition preparation will
lead to the successful transition of the autonomous patient with high self-efficacy seems
to be normative and based on cultural beliefs and values instead on empirical evidence.
Consistent with the findings of other studies, this research has shown that many socially
and economically vulnerable PHIV young adults face insurmountable environmental
barriers after they transitioned to adult HIV care. A greater understanding and response
to social determinants of health may pave the way to more successful transition
programs.
In particular, this research suggested systemic problems in the accessibility and
delivery of adult HIV care and supportive services to help HIV patients manage
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competing challenges, address unmet psychosocial needs, and facilitate the successful
management of HIV disease. Our results highlighted the need for continuing
improvement in the delivery of adult HIV care and supportive services in south Florida,
which will require dedicated resources. While in the past decade resources for HIV/AIDS
research focused on studies concerning adherence to ART medication, attention and
resources should be devoted to the problem of poor engagement in care. Similar to newly
diagnosed adults with HIV, our research findings indicated that the first year in adult HIV
care is crucial to establish care engagement behavior in PHIV young adults.
Interventions to improve retention should focus on the first year post-transition, with
extra attention for those at highest risk of poor engagement, including African-American
or Haitian patients and those living in extreme poverty.
Second, study results suggested a need to re-examine current transition practices
that prepare PHIV young adults individually for transition and transfer patients to adult
care around their 25th birthday. While unintended, these practices may further isolate
PHIV young adults with limited personal social support and who lose the support of the
pediatric team and their peers from the clinic after they had transitioned. Because of the
potential importance of social support in HIV management, this research suggested to
prepare and transition patients in cohorts, instead of individually, and investigate
interventions to establish mutual supportive networks.
Third, program development is a complex process, and neglect in a particular
phase may lead to mistakes and inadequate decisions in subsequent phases. Without a
full appraisal of the problems and possible solutions, interventions may address the
wrong determinants or only address some of the influential determinants and, therefore,
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will not have the desired effect. Notably, social determinants of health are intertwined. To
understand what may play a role, we looked at single factors and their impact on health.
However, public health programs need to use a much broader perspective to include all
(modifiable) factors of importance. Social-ecological theory provides a framework for
assessment of multi-level influences. Planning models should be used to systematically
develop, study, adopt and evaluate innovative strategies; prospective and multi-center
studies are needed to bolster evidence, and ample resources should be made available to
develop evidence-based transition programs.
Finally, traditionally pediatric providers are responsible to prepare their patients
for transition. As transition success is highly dependent on the capacity of adult services
to facilitate transitioned patients, it is recommended that transition programs become a
collaborative effort of pediatric and adult providers. Participants were a crucial source of
information in this research and successful programs should be based on their needs. We
suggest that PHIV young adults play a vital role in the development and implementation
of transition programs. These programs should empower and support transitioning young
adults to take responsibility for management of HIV disease and address structural
constraints.
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Office of Research Integrity
Research Compliance, MARC 270

MEMORANDUM
To:

Dr. Consuelo Beck-Sague

CC:
From:

File
Maria Melendez-Vargas, MIBA, IRB Coordinator

Date:

October 19, 2015

Protocol Title:

"Transitioning HIV-infected young adults to adult clinical care"

The Health Sciences Institutional Review Board of Florida International University has
re-approved your study for the use of human subjects via the Expedited Review process.
Your study was found to be in compliance with this institution’s Federal Wide Assurance
(00000060).
IRB Protocol Approval #:

IRB-14-0298

TOPAZ Reference #:

102881

IRB Approval Date:

10/19/15

IRB Expiration Date: 10/15/16

As a requirement of IRB Approval you are required to:
1) Submit an IRB Amendment Form for all proposed additions or changes in the
procedures involving human subjects. All additions and changes must be reviewed and
approved by the IRB prior to implementation.
2) Promptly submit an IRB Event Report Form for every serious or unusual or
unanticipated adverse event, problems with the rights or welfare of the human subjects,
and/or deviations from the approved protocol.
3) Utilize copies of the date stamped consent document(s) for obtaining consent from
subjects (unless waived by the IRB). Signed consent documents must be retained for
at least three years after the completion of the study.
4) Receive annual review and re-approval of your study prior to your IRB expiration
date. Submit the IRB Renewal Form at least 30 days in advance of the study’s
expiration date.
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5) Submit an IRB Project Completion Report Form when the study is finished or
discontinued.
Special Conditions: N/A
For further information, you may visit the IRB website at http://research.fiu.edu/irb.
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ADULT CONSENT TO PARTICIPATE IN A RESEARCH STUDY
Evaluation of MFCP’s transition program

PURPOSE OF THE STUDY
You are being asked to be in a research study. The purpose of this study is to find out how
former patients of Pediatrics or the Adolescent Clinic are doing after they have transitioned to
adult medical care. Your information and experiences will help us to improve the transition
program.

NUMBER OF STUDY PARTICIPANTS
If you decide to be in this study, you will be one of 120 people in this research study.

DURATION OF THE STUDY
Your participation will take at most 45 minutes.

PROCEDURES
The purpose of this consent form is to help you decide if you wish to be included in this research
study. Please read this form carefully. To be in a research study you must give your informed
consent.
“Informed consent” includes:
• Reading this consent form,
• Having the staff explain the research study
to you,
•
Asking questions about anything that is not
clear.
You should not join this study until all your questions are answered! If you sign this consent
form you assure us that you understand what this study is about and that you voluntarily decide
to participate.
We will get the information we need for this study in two different ways:
1. We will use information about your past treatment history – CD4 count/percentage, HIV
RNA viral load, medical and Emergency Department visit history, HIV-transmission risk
factor, and diagnosis from your medical records. From your psychosocial record, we will
get demographic information (such as your gender, ethnicity, education, household
income and employment). To permit your provider to release your private health
information and to allow us to use your medical information for this study, we will need
you to sign the HIPAA form.
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2. We will ask you to answer a survey. We will ask about your experiences with transition,
what kind of problems you might have had, and how you are doing right now. You will
answer the questions on a laptop computer at the Pediatrics office.

RISKS AND/OR DISCOMFORTS
You need to realize that there might be a small risk that people not authorized will find out you
have participated in this study or will see the information you have provided. To limit these
risks, we have agreed on ways to keep your information as safe as we possibly can. We will keep
your records private and we will not ask you for your name or any other information which
might identify you.

BENEFITS
One of the things we want to find out is whether you were able to get medical care and other
services after transition. Ana Garcia, Barbara Messick, or another MFCP staff member will help
you if this is a problem for you. They will bring you in contact with services, if you wish. Also, the
reason we do this study is to improve the transition program, which will help patients who will
transition in the future.

ALTERNATIVES
There are no known alternatives available to you other than not taking part in this study.

CONFIDENTIALITY
The records of this study will be kept private and will be protected to the fullest extent provided
by law. In any sort of report we might publish, we will not include any information that will
make it possible to identify you. Research records will be stored securely and only the
researcher team will have access to the records. However, your records may be reviewed for
audit purposes by authorized University or other agents who will be bound by the same
provisions of confidentiality.
To help us further protect your privacy, we are applying for a Certificate of Confidentiality from
the National Institutes of Health. With this Certificate, the researchers cannot be forced to
disclose information that may identify you, even by a court subpoena, in any federal, state, or
local civil, criminal, administrative, legislative, or other proceedings. The researchers will use the
Certificate to resist any demands for information that would identify you, except as explained
below.
You should understand that a Certificate of Confidentiality does not prevent you or a member of
your family from voluntarily releasing information about yourself or your involvement in this
research. If an insurer, employer, or other person obtains your written consent to receive
research information, then the researchers may not use the Certificate to withhold that
information.
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The Certificate of Confidentiality does not prevent the researchers from disclosing voluntarily,
without your consent, information that would identify you as a participant in the research
project under the following circumstances: disclosure of child abuse, or intent to hurt self or
others.
The U.S. Department of health and Human Services (DHHS) may request to review and obtain
copies of your records.

COMPENSATION & COSTS
We will give you parking validation and pay for transportation costs you have made to come to
MFCP’s office. If you decide to participate in this study, you will receive $20 in return for your
time and effort. You will not be responsible for any costs to participate in this study.

RIGHT TO DECLINE OR WITHDRAW
Your participation in this study is voluntary. You are free to participate in the study or decide to
withdraw your consent, at any time. Your decision will not affect any benefits to which you are
otherwise entitled. We (the investigators) have the right to remove you without your consent at
such time that we feel it is in the best interest.

RESEARCHER CONTACT INFORMATION
If you have any questions about the purpose, procedures, or any other issues relating to this
study you may contact Susan Biersteker (principal investigator) at FIU. Susan’s phone number is:
(305)494-8415. Susan’s e-mail is: susan.biersteker@yahoo.com.

IRB CONTACT INFORMATION
If you would like to talk with someone about your rights of being a subject in this research study
or about ethical issues with this research study, you may contact the FIU Office of Research
Integrity by phone at 305-348-2494 or by email at ori@fiu.edu.

PARTICIPANT AGREEMENT
I have read the information in this consent form and agree to participate in this study. I have
had a chance to ask any questions I have about this study, and they have been answered for me.
I understand that I am entitled to a copy of this form after it has been read and signed.
________________________________
Signature of Participant

__________________
Date

________________________________
Printed Name of Participant
________________________________

__________________

Signature of Person Obtaining Consent

Date
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Chart Abstraction Form Transition Study
Participant # ______ Completed by: ______________ Date: _____________
Patient Status
o

o
o
o
o
o

A.

Deceased (complete chart abstraction form)
Date (month/year) of death: __________
If deceased: AIDS-related causes o yes o no o unknown
Reached and signed consent/HIPAA (complete chart abstraction form)
Not eligible because of low cognitive functioning (no chart abstraction)
Reached and no consent (no chart abstraction)
Moved outside of S.Florida (no chart abstraction)
Lost to follow-up (no chart abstraction)

Primary Care History

1. Before transitioning, received care at:
o Pediatric Immunology and Infectious Diseases (Pediatric Immunology)
o Adolescent Medicine’s Special Adolescent Clinic (SAC)
2.

Transferred to the pre-transition and/or transition clinic?
o Only pre-transition clinic at Pediatric Immunology or SAC
o Only post-transition clinic at UM/JMC
o Both pre-transition and post-transition clinic
o No
o Unknown

3.

Last medical appointment at Pediatrics /SAC
Month/year of transition:
___________________

4.

Age last appointment at Pediatrics/SAC

5.

Total time of treatment at Pediatrics/SAC? _____ years/months

6.

Transitioned to (adult HIV care):
o Special Immunology Clinic
o Obstetric and Gynecology’s Primary Care Clinic Jackson
o Clinic (other than Jackson)
o Community provider (ASO/CBO)
o Private provider
o Unknown

_____ years/month

B. Socio-Demographics
7.

Year of birth: _____

8.

Gender
o Male
o Female
o Transgender:

O male to female O female to male
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Participant # ______
9.

10.

Race/Ethnicity
o Black or African American, please specify:
O Haitian
O Caribbean
O Other
o
White/non-Hispanic
o
Hispanic, please specify:
O Cuban O Puerto Rican O Mexican O other
o Other
Foreign born?
o Yes
o No
o Unknown

11.

HIV-transmission category
o Perinatal
o Blood products
o Heterosexual
o MSM
o IDU
o Unknown

12.

HIV status biological parents
Mother: O HIV+ O HIVFather: O HIV+ O HIV-

O unknown
O unknown

Mother deceased? 0 yes O no 0 unknown
If yes, age of participant when mother died: ___years
13.

Highest level of education completed
o Did not complete high school
o High school diploma or equivalent
o Vocational/tech program after high school
o College or university (some)
o Unknown

14.

Household income
o Equal or below poverty line
o 101-200% of Federal poverty line
o 201-300% of Federal poverty line
o 301- 400% of Federal poverty line
o ≥401%% of Federal poverty line
o Unknown

143

0 unknown

Participant # ______
15.
o
o
o
o
o
o
16.
o

o
o
o
17.

Employment (more than one answer category possible)
Employed
Unemployed, looking for work
Unemployed, disabled/not healthy enough to work
Enrolled in school
Other ________
Unknown
Health insurance (more than one answer possible)
Yes, please specify:
O Medicaid
O Medicare
O Ryan White
O other public funding source (than Ryan White)
O Private health insurance
Other _____________
No
Unknown

Residence/neighborhood (during 12 months before transition, most of the time)
Zone IV (Liberty City& vicinity): 33147,33150,33138,33167, 33169, 33161)
Zone II (Opa-Locka, Carol City): 33055,33054,33169,33179,33162,33056,33180,33160
Zone V (Little Haiti, Brownsville, part of Liberty City): 33142, 33127, 33157
Zone VI (Little Havana, Overtown): 33125, 33135, 33145,
33136,33128,33130,33129,33132,33131,33109
o Zone X (Homestead, Florida City): 33031,33032,33033,33039,33034,33035
o Other
o Unknown
o
o
o
o

18.
o
o
o
o
o
o

Housing (during 12 months before transition, most of the time)
Homeless (in the street/outdoors/shelter)
Moved around (temporarily in someone’s home)
Lived in own or shared place
Lived with family (f.e.: parent, guardian, grand parent, aunt/uncle, brother/sisters)
Other, please explain __________________________
Unknown

o
o
o
o

Relationship status (at time of transition)
Married
In relationship, but not married
Single
Unknown

19.

20.

Pregnant/children or took care of anyone’s children?
o Yes
o No (skip to 22)
o Unknown (skip to 22)
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Participant # ______
21.
o
o
o
o
o

HIV status biological children
HIV positive
HIV negative
Children have different status
Unknown
N/a: does not have biological child

C. Health Status (most recent information at transition). See also: q24
22.
o
o
o

History of diagnosed depression?
Yes
No
Unknown

23.
Neurodevelopmental assessment
Age of participant (m/y) when tests were conducted: _______
(1). Executive functioning (D-KEFS):
Trails:
Score ____
Qual. : ____________
Verbal Fluency:
Score ____
Qual.: ____________
(2) Attention (CPT)
Omissions:
Score ____
Qual. : ____________
Commissions:
Score ____
Qual.: ____________
HIT SE ISI Change:
Score ____
Qual.: ____________
(3) Memory (WMS-III or WMS-IV)
Auditory Memory Index: Score ____
Qual.: ____________
Visual Memory Index:
Score ____
Qual.: ____________
(4) Achievement/(reading (WJ-III)
Passage comprehension: Score ______
Grade Equivalent ___
(5) Intelligence (WAIS-IV or WASI). FSIQ: _________________
24.

CD4 count, viral load and adherence to ART
Baseline: Pretransition. Last
results at
Pediatrics/SAC

Post-transition: 1
year after
transition

Post transition:
2 years after
transition

Post transition: most
recent
information (i.e.
currently)

0 yes
0 no
0 unknown
O ART not
prescribed

0 yes
0 no
0 unknown
O ART not prescribed

0 yes
0 no
0 unknown
O ART not prescribed

0 yes
0 no
0 unknown
O ART not prescribed

Clinical category
HIV disease
staging
CD4 count
Viral load
Non-compliance
to ART?
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Participant # ______
25. Number of made & kept appointments with HIV provider
1st quarter:
1- 3 months
Made Kept

2nd quarter:
4-6 months
Made Kept

3rd quarter:
7-9 months
Made Kept

4th quarter:
10-12 months
Made Kept

Baseline:
Last 12 months
at SAC/Pediatrics
Follow-up:
1 year posttransition
Follow-up:
2 year posttransition
Follow-up:
In the past 12
months

26. Number of made & kept appointments with case manager
Made
Kept
Baseline:
last 12 months at
SAC/Pediatrics
Follow-up:
1 year post-transition
Follow-up:
2 year post-transition
Follow-up:
In the past 12 months

27. Total number of E.R. visits & hospital admissions
E.R.
Baseline:
Last 12 months at SAC/Pediatrics
Follow-up:
1 year post-transition
Follow-up:
2 year post-transition
Follow-up:
In the past 12 months
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Hospital

Participant # ______
28. General remarks (do not include private information)
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
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SUSAN BIERSTEKER
Born in Heerhugowaard, The Netherlands.
1975-1979

B.A. Education.
Bijzondere Neutrale Academie, Den Helder, The Netherlands

1979-1980

Teacher Elementary Education
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B.A. Behaviorial Sciences
University of Amsterdam, Amsterdam, The Netherlands

1982-1986

Teacher Illiteracy Courses
Amsterdam, The Netherlands
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Degree of Doctorandus (Drs) in Behaviorial Sciences
University of Amsterdam, Amsterdam, The Netherlands
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Counselor
Hubertus Huis, Amsterdam, The Netherlands

1988-1994

Coordinator Dutch National HIV/STD Prostitution Policy
Foundation for STD Control, Utrecht, The Netherlands

1990

International EIS Course in Epidemiology (Certificate)
Emory University and Centers for Disease Control and Prevention
(CDC)

1995-2001

Founding Board Member and Program Director
South Beach AIDS Project, Miami Beach, Fl.

2003-current

Program Planning and Evaluation Consultant
Behavioral Research and Evaluation Consultants, Miami, Fl.
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